<!DOCTYPE html>
<!--[if lt IE 7]> <html lang="en" class="ie ie6 lte9 lte8 lte7 os-other"> <![endif]-->
<!--[if IE 7]> <html lang="en" class="ie ie7 lte9 lte8 lte7 os-other"> <![endif]-->
<!--[if IE 8]> <html lang="en" class="ie ie8 lte9 lte8 os-other"> <![endif]-->
<!--[if IE 9]> <html lang="en" class="ie ie9 lte9 os-other"> <![endif]-->
<!--[if gt IE 9]> <html lang="en" class="os-other"> <![endif]-->
<!--[if !IE]><!--> <html lang="en" class="os-other"> <!--<![endif]-->
<head>
<script src="http://static.licdn.com:80/scds/common/u/lib/fizzy/fz-1.3.6-min.js" type="text/javascript"></script><script type="text/javascript">fs.config({"failureRedirect":"http://www.linkedin.com/nhome/","uniEscape":true,"xhrHeaders":{"X-FS-Origin-Request":"/in/reidrubsamenmd","X-FS-Page-Id":"nprofile-public-vanity"}});</script><script></script>
<meta name="globalTrackingUrl" content="//www.linkedin.com/mob/tracking">
<meta name="globalTrackingAppName" content="profile">
<meta name="globalTrackingAppId" content="webTracking">
<meta name="lnkd-track-json-lib" content="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=2jds9coeh4w78ed9wblscv68v-ebbt2vixcc5qz0otts5io08xv&amp;fc=2">
<meta name="lnkd-track-lib" content="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=ebbt2vixcc5qz0otts5io08xv&amp;fc=2">
<meta name="treeID" content="lk8IqaE4qRPw5s2M6SoAAA==">
<meta name="appName" content="profile">
<meta name="lnkd-track-error" content="/lite/ua/error?csrfToken=ajax%3A8819885718929664622">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="pageImpressionID" content="cdba14cc-f3e9-4731-9ab2-9b1471f0cdba">
<meta name="pageKey" content="nprofile_v2_public_fs">
<meta name="analyticsURL" content="/analytics/noauthtracker">
<link rel="openid.server" href="https://www.linkedin.com/uas/openid/authorize">
<link rel="apple-touch-icon-precomposed" href="http://s.c.lnkd.licdn.com/scds/common/u/img/icon/apple-touch-icon.png">
<!--[if lte IE 8]>
  <link rel="shortcut icon" href="http://s.c.lnkd.licdn.com/scds/common/u/images/logos/favicons/v1/16x16/favicon.ico">
<![endif]-->
<!--[if IE 9]>
  <link rel="shortcut icon" href="http://s.c.lnkd.licdn.com/scds/common/u/images/logos/favicons/v1/favicon.ico">
<![endif]-->
<link rel="icon" href="http://s.c.lnkd.licdn.com/scds/common/u/images/logos/favicons/v1/favicon.ico">
<meta name="msapplication-TileImage" content="http://s.c.lnkd.licdn.com/scds/common/u/images/logos/linkedin/logo-in-win8-tile-144_v1.png"/>
<meta name="msapplication-TileColor" content="#0077B5"/>
<meta name="application-name" content="LinkedIn"/>
<link rel="stylesheet" type="text/css" href="http://s.c.lnkd.licdn.com/scds/concat/common/css?h=3bifs78lai5i0ndyj1ew7316e-c8kkvmvykvq2ncgxoqb13d2by-38so5ftc5lv2bbm0jf5rvv1qj-7mxyksftlcjzimz2r05hd289r-4uu2pkz5u0jch61r2nhpyyrn8-7poavrvxlvh0irzkbnoyoginp-4om4nn3a2z730xs82d78xj3be-mea0xb6thaagfbcx9i1vg82z-ct4kfyj4tquup0bvqhttvymms-83892l068mw9yvt4t3qj386b0-9zbbsrdszts09by60it4vuo3q-8ti9u6z5f55pestwbmte40d9-ej816lvgg0knmb99hj57wpnqe-3pwwsn1udmwoy3iort8vfmygt-b1019pao2n44df9be9gay2vfw-aau7s6f37xbtq1daynn0bb656-ab01tg8funn2n1exayaej7367&amp;fc=2">
<script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=3nuvxgwg15rbghxm1gpzfbya2-35e6ug1j754avohmn1bzmucat-mv3v66b8q0h1hvgvd3yfjv5f-14k913qahq3mh0ac0lh0twk9v-1odoqm6uqzmutse6kyk5satus-b7ksroocq54owoz2fawjb292y-62og8s54488owngg0s7escdit-c8ha6zrgpgcni7poa5ctye7il-8gz32kphtrjyfula3jpu9q6wl-51dv6schthjydhvcv6rxvospp-e9rsfv7b5gx0bk0tln31dx3sq-2r5gveucqe4lsolc3n0oljsn1-8v2hz0euzy8m1tk5d6tfrn6j-3eh5zbf8m3976frnzqqz8r2md-1hr5130uetdb7etkt1siyn80c-8zc7dy7k0uqxxso1zmcx40mxo-a7br995b5xb4ztral63cjods4-1j5yeidfdiltik0gx4ekvcwvk-9wkskbn6s2q25rkbrnuwlqric-39kuwv80yvqr74w4oe9bge0md-ejfdcbibyn0amjrpy1bw898cw-2ktfa1kftfo63s0zzwtqt9mf0-b0otj9zjsih2zu4s3gxjejik2-czstax4e6y68hymdvqxpwe5so-3g8gynfr7fip2svw23i5ixnw3&amp;fc=2"></script>
<script type="text/javascript">LI.define('UrlPackage');LI.UrlPackage.containerCore=["http://s.c.lnkd.licdn.com/scds/concat/common/js?h=d7z5zqt26qe7ht91f8494hqx5&fc=2"][0];</script>
<script type="text/javascript">if(typeof LI==='undefined'||!LI){window.LI={};}
LI.JSContentBasePath="http://s.c.lnkd.licdn.com/scds/concat/common/js?v=build-1197_8_40780-prod&fc=2";LI.CSSContentBasePath="http://s.c.lnkd.licdn.com/scds/concat/common/css?v=build-1197_8_40780-prod&fc=2";LI.injectRelayHtmlUrl="http://s.c.lnkd.licdn.com/scds/common/u/lib/inject/0.4.2/relay.html";LI.injectRelaySwfUrl="http://s.c.lnkd.licdn.com/scds/common/u/lib/inject/0.4.2/relay.swf";LI.comboBaseUrl="http://s.c.lnkd.licdn.com/scds/concat/common/css?v=build-1197_8_40780-prod&fc=2";LI.staticUrlHashEnabled=true;</script>
<script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=25kaepc6rgo1820ap1rglmzr4-c19zsujfl1pg46iqy33ubhqc5-c5ebkkd7pexovk435l30l1dq5-ascppxxu6dqpt5sppka77kdt0-39o2kw4renyd4i8pt5n9x0qaz-9cttgd1ueltkur8cb164nt1vt-eehwe5piqwg4elnl8jvj9vpx-amjylk8w8039f2lwlov2e4nmc-47qp7uw3i5i1pqeovirlcc070-3xqgp8jf23j83i1nnx1yxga4o-ayxwbavi1xwiu87tdhsu4heu1-9zfstbzn70th5stecee7kg1e1-9undj1hjru2i7vjjlqtb52ho2-7vr4nuab43rzvy2pgq7yvvxjk-4yhpyv3p9r574wkkbe8kcd2ou&amp;fc=2"></script>
<script type="text/javascript">fs._server.fire("964f08a9a138a913f0e6cd8ce92a0000-1",{event:"before",type:"html"});</script><meta name="remote-nav-init-marker" content="true"/>
<link rel="stylesheet" type="text/css" href="http://s.c.lnkd.licdn.com/scds/concat/common/css?h=83892l068mw9yvt4t3qj386b0-3tmlqn54dgd1ymxy3ax2ltxhc">
<script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=ditm8xdycl29ta8gqk5tpmxf8-czstax4e6y68hymdvqxpwe5so"></script>
<script type="text/javascript">fs._server.fire("964f08a9a138a913f0e6cd8ce92a0000-1",{event:"after",type:"html"});</script>
<script type="text/javascript">document.cookie='lang="v=2&lang=en-us"; domain=linkedin.com; version=0; path=/;';</script><title>Reid Rubsamen, M.D. | LinkedIn</title>
<link rel="stylesheet" type="text/css" href="http://s.c.lnkd.licdn.com/scds/concat/common/css?h=c52xqty03kc2uumayfdgw52ha-bk92zz77hzhkgsw77ffvbn099-9isvvzw61fpveso9doy1mzsas-dxl1g2k3wk6qpss8oq9lwul9c-95t6vcl2cgpx3042md6zm5jzo&amp;fc=2">
<script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=4zslye83akez5s4mf91hrq425-95d8d303rtd0n9wj4dcjbnh2c-b0i2ltvivggf15dlzc359ook3-7r1hr0x81n4m5vdil2awiladb-alv1b6ogz9d0wdvu14407mm19-2xkrig2d2e38eolz4s6d5kfkh-cnwrlx66cjysnsrzwzhp0936t&amp;fc=2"></script>
<meta name="description" content="View Reid Rubsamen, M.D.&#39;s professional profile on LinkedIn. LinkedIn is the world&#39;s largest business network, helping professionals like Reid Rubsamen, M.D. discover inside connections to recommended job candidates, industry experts, and business partners."/>
<link rel="canonical" href="https://www.linkedin.com/in/reidrubsamenmd"/>
<script type="text/javascript" src="https://www.linkedin.com/uas/authping?url=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fin%2Freidrubsamenmd"></script>
<meta name="robots" content="noarchive">
<link rel="stylesheet" type="text/css" href="http://s.c.lnkd.licdn.com/scds/concat/common/css?h=dh9s2pgf6ghcuifobl7cvitf9-9l99zlwrehf6a29tfenyn0y3c-4hiq25ev1kaxjre7x476dwm77-4fejnuzeayte4jf04by07n71m-d9n6w9woameilexmmaj4je36f-alg1xassjoiiwbcn1pabeu5s1&amp;fc=2">
<link rel="stylesheet" type="text/css" href="http://s.c.lnkd.licdn.com/scds/concat/common/css?h=asv5csgijnlhmxevx9iyksgx0-16908gwxeyxmnaseb2dcuc1re-el4kv63fu6gqcefwktcvbt5mr-ebsvwtq37n6zk5hpumk8wkyzx-7ovfg7vxns6r11kowagi6b1sl-3jwa0iljvjbntb50hywszyrd5&amp;fc=2">
<link rel="stylesheet" type="text/css" href="http://s.c.lnkd.licdn.com/scds/concat/common/css?h=2jrag6lgkecaey7v8m2az267t-497ziitmdlf98eot25sfmagg9-3daoqimyqbbjdvx60nyur08pl-ba2tirfqlpr4sxnqihowtvb4z-668nv4nehgxq542wxh6t6bcu1-4c4jvb131w14g7f5wo9mbkrqv-5yq3ug0mq7ait7ppz3mk6y4kr&amp;fc=2">
<script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=4hbqp7aoxoph1cnia8g1cujwf-67g2wtemxsi3axtp2922jzpbc-7mba7idrrujfs4x7vi3ej72dn-9c0l1n6a22b4tj62r0x1frfe8-d2la7obrbyceb8fp1fvppfzea-e17zy6z51dugr6fy4su92o7de-2axsz5yfnd6bwcna2ram04kr0&amp;fc=2"></script>
<script type="text/javascript">LI.define('profile.viewType');LI.profile.viewType='';if(!LI.p2Dialogs){LI.p2Dialogs={cssFiles:["http://s.c.lnkd.licdn.com/scds/concat/common/css?h=cfsam81o5sp3cxb7m0hs933c4-9l99zlwrehf6a29tfenyn0y3c&fc=2"]};}
if(dust&&!dust.imgDefer){dust.imgDefer={imgDeferUsed:true}}</script>
</head>
<body dir="ltr" class="guest v2  chrome-v5 chrome-v5-responsive sticky-bg guest" id="pagekey-nprofile_v2_public_fs">
<input id="inSlowConfig" type="hidden" value="false"/>
<script type="text/javascript">document.body.className+=" js ";</script>
<script type="text/javascript">fs._server.fire("964f08a9a138a913f0e6cd8ce92a0000-2",{event:"before",type:"html"});</script><div id="a11y-menu" class="a11y-skip-nav-container">
<div class="a11y-skip-nav a11y-hidden">
<a href="#a11y-content" id="a11y-skip-nav-link">Skip to main content</a>
</div>
<script id="control-http-12274-exec-17934225-1" type="linkedin/control" class="li-control">LI.Controls.addControl('control-http-12274-exec-17934225-1','A11yMenu',{jumpToText:'Jump to: <strong>Summary<\/strong>',skipToText:'Skip to: <strong>Search<\/strong>',feedbackText:'Accessibility Feedback',closeText:'close',anchorText:'Content Follows:',moreText:'More in-page navigation options below',smallPageText:'Not much to look at here. Go directly to content.',searchUrl:'/vsearch/f'});</script>
<script id="control-http-12274-exec-17934225-2" type="linkedin/control" class="li-control">LI.KbDialogDependencies={jsFiles:["http://s.c.lnkd.licdn.com/scds/concat/common/js?h=37zc8dm8vu14f1neta1ponx0o"],cssFiles:["http://s.c.lnkd.licdn.com/scds/concat/common/css?h=9qwmbyyfabl3upqh3cyzbhd49"]};LI.Controls.addControl('control-http-12274-exec-17934225-2','kb.shortcuts',{homepageUrl:'http:\/\/www.linkedin.com\/nhome\/?trk=global_kb',profileUrl:'http:\/\/www.linkedin.com\/profile\/view?trk=global_kb',editProfileUrl:'http:\/\/www.linkedin.com\/profile\/edit?trk=global_kb',inboxUrl:'http:\/\/www.linkedin.com\/inbox\/#messages?trk=global_kb',jobsUrl:'http:\/\/www.linkedin.com\/job\/home?trk=global_kb',settingsUrl:'https:\/\/www.linkedin.com\/secure\/settings?req=&trk=global_kb',influencerUrl:'http:\/\/www.linkedin.com\/influencers?trk=global_kb'});</script>
</div>
<div id="header" class="global-header responsive-header nav-v5-2-header responsive-1 remote-nav" role="banner">
<div id="top-header">
<div class="wrapper">
<h2 class="logo-container">
<a href="http://www.linkedin.com/" class="logo" id="li-logo">
LinkedIn Home
</a>
</h2>
<ul class="nav main-nav guest-nav" role="navigation">
<li class="nav-item">
<a href="/static?key=what_is_linkedin&amp;trk=hb_what" class="nav-link">
What is LinkedIn?
</a>
</li>
<li class="nav-item">
<a href="https://www.linkedin.com/reg/join?trk=hb_join" class="nav-link" rel="nofollow">
Join Today
</a>
</li>
<li class="nav-item">
<a href="https://www.linkedin.com/uas/login?goback=%2Enppvan_reidrubsamenmd&amp;trk=hb_signin" class="nav-link" rel="nofollow">
Sign In
</a>
</li>
</ul>
</div>
</div>
<div class="a11y-content">
<a name="a11y-content" tabindex="0" id="a11y-content-link">Main content starts below.</a>
</div>
</div>
<script type="text/javascript">LI.RUM=LI.RUM||{};LI.RUM.streamMetrics={timeToNavInteractive:Date.now&&Date.now()||new Date().getTime(),timeToAboveFold:null,timeToPageInteractive:null};</script>
<script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=62og8s54488owngg0s7escdit-8gz32kphtrjyfula3jpu9q6wl-aujmp9r1kj9k9x4ezyk8ahfbk-62cjxbtqyt2o85tawwwz12otx-a2blfu8y091887ailkls7jxq3-d25t3jwqpgzv7njh2nak0ihfd-4h7jw6m1hgmxfhfff4aqk85ga-6tyvplvemczf4qdrlxny6lq8d-8ugx4n599hqrhz6defhnrcalx-3i7ubdukif1jevuf29ftmtvjs-ukgkg4rtwlz74z78bt35jocx-5cmfpe4jqrweez449s97ldikg-clz7gb1h1gqkujqk14gbprnf5"></script>
<script type="text/javascript">fs._server.fire("964f08a9a138a913f0e6cd8ce92a0000-2",{event:"after",type:"html"});</script>
<div id="body" class="" role="main">
<div class="wrapper hp-nus-wrapper">
<div id="global-error">
</div>
<div id="wrapper" class="public-profile">
<div id="profile">
<script type="text/javascript">if(window.fs){fs.after('public_top_card',function(id){LI.profile.modInit.addAndFlush(id,LI.profile.modules.topcard);});}</script>
<script type="text/javascript">fs._server.fire("public_top_card",{event:"before",type:"html"});</script><script type="text/javascript">LI.i18n.register('IntrosDialogStub-default-title','Introduction Request');if(!LI.IntrosDialogDependencies){LI.IntrosDialogDependencies={jsFiles:'http://s.c.lnkd.licdn.com/scds/concat/common/js?h=3m0wwwerqvp8618uhx52in5b-7dtuvg1c0abi4ci2xeq2sfs2d&amp;fc=2',cssFiles:'http://s.c.lnkd.licdn.com/scds/concat/common/css?h=9uas09rvrig812gppe8pezdm5-2wjjionwkrvna3b1prar6d0qr-2parkkfu6rvpuoklqbawocoyo&amp;fc=2'};}</script><!--Enjoy our markup--><div id="top-card" data-li-template="top_card"><img id="in-logo-mobile" src="http://s.c.lnkd.licdn.com/scds/common/u/images/logos/linkedin/logo_in_nav_44x36.png" width="30" height="24" alt="LinkedIn"/><img src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_500_500/p/8/005/03e/2bf/09e49f7.jpg" width="500" height="500" id="bg-blur-profile-picture" alt="Reid Rubsamen, M.D."/><div id="top-card-overlay"></div><div class="profile-top-card top-card "><div class="profile-card vcard"><div class="profile-picture"><a href="https://www.linkedin.com/reg/join-pprofile?_ed=0_1juIla4xhA4CFr0Cj73Lsht1xr0t0ZUqIgoujj7RAh3sKLgxXcQStAhkFshIq3pz2-cfEKSe5lACsAcFZZguvL&amp;trk=pprof-0-ts-view_full-0"> <img src='http://m.c.lnkd.licdn.com/mpr/mpr/shrink_200_200/p/8/005/03e/2bf/09e49f7.jpg' width="200" height="200" alt="Reid Rubsamen, M.D."/> </a><span></span></div><div class="profile-overview"><div class="profile-overview-content"><div id="member-21917952" class="masthead"><div data-li-template="p2_basic_info"><div id="name-container" data-li-template="name"><div id="name" class="editable-item"><h1><span class="n fn"><span class="full-name">Reid Rubsamen, M.D.</span><span></span></span></h1></div></div><div id="headline-container" data-li-template="headline"><div id="headline" class="editable-item"><p class="title ">CEO and Co-Founder at Immunity Project</p></div></div><div class="demographic-info adr editable-item" id="demographics"><div id="location-container" data-li-template="location"><div id="location" class="editable-item"><dl><dt>Location</dt><dd><span class="locality">San Francisco Bay Area</span></dd><dt>Industry</dt><dd class="industry">Hospital & Health Care</dd></dl></div></div></div></div></div><table summary="Overview for Reid Rubsamen, M.D."><tr id="overview-summary-current"><th scope="row"><a href="#background-experience" data-trk="ppro_cprof">Current</a></th><td><ol><li><a href="/company/5034971?trk=ppro_cprof">Immunity Project</a>, </li><li><a href="/company/2896?trk=ppro_cprof">Massachusetts General Hospital</a>, </li><li><a href="/company/16913?trk=ppro_cprof">John Muir Health</a></li></ol></td></tr><tr id="overview-summary-past"><th scope="row"><a href="#background-experience" data-trk="ppro_cprof">Previous</a></th><td><ol><li><a href="/company/17261?trk=ppro_cprof">Aradigm Corporation</a>, </li><li><a href="/company/2896?trk=ppro_cprof">Massachusetts General Hospital</a></li></ol></td></tr><tr id="overview-summary-education"><th scope="row"><a href="#background-education" data-trk="ppro_sprof">Education</a></th><td><ol><li><a href="/edu/school?id=18494&trk=ppro_sprof" title="More details for this school">Massachusetts Institute of Technology</a></li></ol></td></tr><tr id="overview-summary-websites"><th scope="row">Websites</th><td><ul><li><a target="_blank" href="/redir/redirect?url=http%3A%2F%2Fwww%2Emacmgi%2Ecom&urlhash=y8s8&trk=ppro_website">Company Website</a></li><li><a target="_blank" href="/redir/redirect?url=http%3A%2F%2Fwww%2Eimmunityproject%2Eorg&urlhash=AJyP&trk=ppro_website">Company Website</a></li><li><a target="_blank" href="/redir/redirect?url=http%3A%2F%2Fwww%2Eflowpharma%2Ecom&urlhash=wlya&trk=ppro_website">Company Website</a></li></ul></td></tr></table></div><div class="profile-aux"><div class="member-connections"><strong>500+</strong>connections</div></div><!-- /profile-aux --></div><!-- End profile-overview --><div id="signup-link-tile-bg"><div class="blur-layer"><p>Join LinkedIn & access Reid's full profile</p><div id="circle-join-btn"><div class="person-icon"></div></div></div></div><a href="https://www.linkedin.com/reg/join-pprofile?_ed=0_1juIla4xhA4CFr0Cj73Lsht1xr0t0ZUqIgoujj7RAh3sKLgxXcQStAhkFshIq3pz2-cfEKSe5lACsAcFZZguvL&amp;trk=pprof-0-ts-view_full-0" id="signup-link-tile"><p>Join LinkedIn & access Reid's full profile</p></a></div><!-- End profile card --><div class="public-reg-upsell"><h2>Join LinkedIn &amp; access Reid's full profile. It's free!</h2><h3>As a LinkedIn member, you&#39;ll join 300 million other professionals who are sharing connections, ideas, and opportunities.</h3><ul><li>See who you know in common</li><li>Get introduced</li><li>Contact Reid directly</li></ul><a href="https://www.linkedin.com/reg/join-pprofile?_ed=0_1juIla4xhA4CFr0Cj73Lsht1xr0t0ZUqIgoujj7RAh3sKLgxXcQStAhkFshIq3pz2-cfEKSe5lACsAcFZZguvL&amp;trk=pprof-0-ts-view_full-0" class="signup-button">View Reid's Full Profile</a></div></div></div><div id="highlight-module"><div class="member-connections"><strong>500+</strong>connections</div><div class="highlight-slot"><img src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_80_80/p/2/005/037/163/1aed3c2.png" class="organization-icon" alt="Immunity Project" width="45" height="45"/><div class="content"><h3>Immunity Project</h3><p>CEO and Co-Founder</p><p><time>October 2010</time> &#8211; Present</p></div></div></div><a href="https://www.linkedin.com/reg/join-pprofile?_ed=0_1juIla4xhA4CFr0Cj73Lsht1xr0t0ZUqIgoujj7RAh3sKLgxXcQStAhkFshIq3pz2-cfEKSe5lACsAcFZZguvL&amp;trk=pprof-0-ts-view_full-0" id="full-profile-btn-link">View full profile</a><script type="text/javascript">fs._server.fire("public_top_card",{event:"after",type:"html"});</script>
<script type="text/javascript">fs._server.fire("profile_v2_background_view",{event:"before",type:"html"});</script><div id="background" class="profile-background"><h2>Background</h2><div class="background-content "><div id="background-summary-container" class="background-section " data-li-template="summary_section"><div id="background-summary" class="background-summary edit-default"><div class="summary-header"><h3>Summary</h3></div><div id="summary-item" class="editable-item section-item"><div id="summary-item-view"><div class="summary"><p class="description">Dr. Rubsamen is a Board Certified anesthesiologist having received his medical training at Pacific Medical Center, San Francisco and Massachusetts General Hospital, where in 1989 he served as Chief Resident in Anesthesia. He was also a doctoral candidate in the computer science department at the Massachusetts Institute of Technology, leaving in 1990 to found Aradigm Corporation. He left Aradigm in 2000 to enter private practice and found Immunity Project. Dr. Rubsamen holds an A.B. in<br>
biochemistry and computer science from the University of California, Berkeley, and an M.S. in computer science and an M.D. from Stanford University. Dr. Rubsamen is a named inventor of more than 65 issued U.S. patents. Dr. Rubsamen is Director and CEO of Flow Pharma, Inc and the CEO<br>
and Co- Founder of Immunity Project.<br>
<br>
Specialties: <br>
<br>
-Board Certified Anesthesiologist<br>
-Digital Signal Processing and Mixed Signal Engineer. <br>
-Additional expertise in pharmaceutical chemistry, novel dosage form development and regulatory affairs leading to 510(k) and IND filings in the US as well as filings for clinical trials in the UK, Australia and the Netherlands.</p></div></div></div></div></div><div id="background-experience-container" class="background-section" data-li-template="experience_section"><div id="background-experience" class="background-experience edit-default "><h3>Experience</h3><div id="experience-504286116" class="editable-item section-item current-position"><div id="experience-504286116-view"><header><h5 class="experience-logo"><a href="/company/5034971?trk=ppro_cprof"><img src="http://m.c.lnkd.licdn.com/media/p/2/005/037/163/1aed3c2.png" alt="Immunity Project"/></a></h5><h4>CEO and Co-Founder</h4><h5><a href="/company/5034971?trk=ppro_cprof">Immunity Project</a></h5></header><span class="experience-date-locale"><time>October 2010</time> &#8211; Present (4 years 2 months)</span><p class="description summary-field-show-more">Immunity Project is a Y Combinator backed non profit organization dedicated to developing an HIV vaccine and distributing it worldwide for free.</p></div></div><div id="experience-472994405" class="editable-item section-item current-position"><div id="experience-472994405-view"><header><h5 class="experience-logo"><a href="/company/2896?trk=ppro_cprof"><img src="http://m.c.lnkd.licdn.com/media/p/3/000/01b/259/30376f4.png" alt="Massachusetts General Hospital"/></a></h5><h4>Consultant, Anesthesia and Critical Care</h4><h5><a href="/company/2896?trk=ppro_cprof">Massachusetts General Hospital</a></h5></header><span class="experience-date-locale"><time>October 2011</time> &#8211; Present (3 years 2 months)<span class="locality">Greater Boston Area</span></span></div></div><div id="experience-116883389" class="editable-item section-item current-position"><div id="experience-116883389-view"><header><h5 class="experience-logo"><a href="/company/16913?trk=ppro_cprof"><img src="http://m.c.lnkd.licdn.com/media/p/2/000/021/2de/0146fb4.png" alt="John Muir Health"/></a></h5><h4>Medical Director, Surgical Services</h4><h5><a href="/company/16913?trk=ppro_cprof">John Muir Health</a></h5></header><span class="experience-date-locale"><time>January 2004</time> &#8211; Present (10 years 11 months)</span><p class="description summary-field-show-more">OR Medical Director for the Trauma Center for Contra Costa County</p></div></div><div id="experience-33656425" class="editable-item section-item current-position"><div id="experience-33656425-view"><header><h4>Founder/President/Board Member</h4><h5>Flow Pharma, Inc.</h5></header><span class="experience-date-locale"><time>June 2002</time> &#8211; Present (12 years 6 months)</span><p class="description summary-field-show-more">CEO</p></div></div><div id="experience-75156086" class="editable-item section-item current-position"><div id="experience-75156086-view"><header><h5 class="experience-logo"><a href="/company/56945?trk=ppro_cprof"><img src="http://m.c.lnkd.licdn.com/media/p/7/000/208/324/373bbba.png" alt="MAC/Sheridan Healthcorp"/></a></h5><h4>Physician/Board Member</h4><h5><a href="/company/56945?trk=ppro_cprof">MAC/Sheridan Healthcorp</a></h5></header><span class="experience-date-locale"><time>June 2002</time> &#8211; Present (12 years 6 months)</span><p class="description summary-field-show-more">Chairman, Risk Management Committee</p></div></div><div id="experience-75156175" class="editable-item section-item past-position"><div id="experience-75156175-view"><header><h4>Founder/VP Medical Affairs</h4><h5><a href="/company/17261?trk=ppro_cprof">Aradigm Corporation</a></h5></header><span class="experience-date-locale"><time>June 1991</time> &#8211; <time>June 2001</time> (10 years 1 month)</span><p class="description summary-field-show-more">Helped build Aradigm into a 250-person company with full pharmaceutical and medical device development infrastructure sufficient to bring the lead program, inhaled insulin, to market.</p></div></div><div id="experience-75156912" class="editable-item section-item past-position"><div id="experience-75156912-view"><header><h5 class="experience-logo"><a href="/company/2896?trk=ppro_cprof"><img src="http://m.c.lnkd.licdn.com/media/p/3/000/01b/259/30376f4.png" alt="Massachusetts General Hospital"/></a></h5><h4>Clinical Fellow/Staff Physician</h4><h5><a href="/company/2896?trk=ppro_cprof">Massachusetts General Hospital</a></h5></header><span class="experience-date-locale"><time>July 1990</time> &#8211; <time>June 1991</time> (1 year)</span><p class="description summary-field-show-more">Trained residents and fellows. Continued graduate studies at MIT.</p></div></div><div id="experience-75156613" class="editable-item section-item past-position"><div id="experience-75156613-view"><header><h5 class="experience-logo"><a href="/company/2896?trk=ppro_cprof"><img src="http://m.c.lnkd.licdn.com/media/p/3/000/01b/259/30376f4.png" alt="Massachusetts General Hospital"/></a></h5><h4>Chief Resident, Anesthesia</h4><h5><a href="/company/2896?trk=ppro_cprof">Massachusetts General Hospital</a></h5></header><span class="experience-date-locale"><time>January 1989</time> &#8211; <time>June 1989</time> (6 months)</span><p class="description summary-field-show-more">Responsible for 60 residents and fellows. Simultaneously a post-doctoral fellow at the Laboratory of Computer Science at MIT.</p></div></div><script>$(function(){if(LI.Dialog){LI.Dialog().submitEvent.subscribe(function(type,args){var positionID;if(args[1]=='removePositionDialog'&&WebTracking&&WebTracking.trackUserAction){if(args[2]&&args[2].positionID){positionID=args[2].positionID;}WebTracking.trackUserAction('nprofile-edit-position-remove-submit',{positionID:positionID});}});}});</script></div></div><div id="background-patents-container" class="background-section" data-li-template="patents_section"><div id="background-patents" class="background-patents "><h3>Patents</h3><div id="patent-356" class="editable-item section-item"><div id="patent-356-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fappft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtml%26r%3D2%26p%3D1%26f%3DG%26l%3D50%26d%3DPG01%26S1%3Drubsamen%2EIN%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=fSu8&trk=prof-patent-title-link" name="patent-site" target="_blank">VACCINE FORMULATION OF MANNOSE COATED PEPTIDE PARTICLES<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 20120231044 </h5></hgroup><span class="patents-date">Filed&nbsp;September 13, 2012</span><p class="description summary-field-show-more">A vaccine formulation as disclosed which is comprised of a pharmaceutically acceptable carrier in a plurality of particles with mannose on their surface. The particles are comprised of a biocompatible polymer which maybe a co-polymer such as PLGA combined with a peptide of a sequence which corresponds to a sequence on a surface of a pathogen. A plurality of different groups of particles are provided in the formulation wherein the particles within any single group include peptides of identical amino acid sequence. The particles are sized such that they are sufficiently large so as to prevent more than a single particle from being presented to a single immune system cell.</p><script type="text/javascript">LI.i18n.register('ShowMore-see-more','more');LI.i18n.register('ShowMore-see-less','less');LI.i18n.register('ShowMore-see-more-long','Show more');LI.i18n.register('ShowMore-see-less-long','Show less');</script><script id="control-dust-server-29949745-3" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-3","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-3";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/charles-vincent-herst/10/aa3/11a">Charles Vincent Herst</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a></li></ul></dd></dl></div></div><div id="patent-353" class="editable-item section-item"><div id="patent-353-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fappft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtml%26r%3D4%26p%3D1%26f%3DG%26l%3D50%26d%3DPG01%26S1%3Drubsamen%2EIN%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=tBBl&trk=prof-patent-title-link" name="patent-site" target="_blank">PEPTIDE PARTICLE FORMULATION<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 20110300226 </h5></hgroup><span class="patents-date">Filed&nbsp;December 8, 2011</span><p class="description summary-field-show-more">A composition as disclosed is comprised of a plurality of groups of particles. The particles are comprised of a biocompatible polymer which maybe a co-polymer such as PLGA combined with a peptide of a sequence of interest, e.g. a sequence which corresponds to a sequence presented on a surface of a cell infected with a virus. A plurality of different groups of particles are provided in the formulation wherein the particles within any single group include peptides of identical amino acid sequence. The particles are sized such that they are sufficiently large so as to prevent more than the contents of a single particle from being presented to a single immune system cell.</p><script id="control-dust-server-29949745-4" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-4","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-4";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>David Heckerman</li></ul></dd></dl></div></div><div id="patent-350" class="editable-item section-item"><div id="patent-350-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fappft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtml%26r%3D1%26p%3D1%26f%3DG%26l%3D50%26d%3DPG01%26S1%3Drubsamen%2EIN%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=Y2fE&trk=prof-patent-title-link" name="patent-site" target="_blank">PEPTIDE PARTICLE FORMULATION<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 20130142878 </h5></hgroup><span class="patents-date">Filed&nbsp;November 30, 2012</span><p class="description summary-field-show-more">A composition as disclosed is comprised of a plurality of groups of particles. The particles are comprised of a biocompatible polymer which may be a co-polymer such as PLGA combined with a peptide of a sequence of interest, e.g. a sequence which corresponds to a sequence presented on a surface of a cell infected with a virus. A plurality of different groups of particles are provided in the formulation wherein the particles within any single group include peptides of identical amino acid sequence. The particles are sized such that they are sufficiently large so as to prevent more than the contents of a single particle from being presented to a single immune system cell.</p><script id="control-dust-server-29949745-5" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-5","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-5";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>David Heckerman</li></ul></dd></dl></div></div><div id="patent-75" class="editable-item section-item"><div id="patent-75-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D1%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=FGMp&trk=prof-patent-title-link" name="patent-site" target="_blank">Antibiotic formulation and method of treatment<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 8,138,157 </h5></hgroup><span class="patents-date">Issued&nbsp;March 20, 2012</span><p class="description summary-field-show-more">A formulation comprised of particles which may be in groups and are comprised of a biocompatible polymer and an antimicrobial drug for controlled release of the drug is disclosed. The particles may be in an aqueous solution comprising thrombin and be dispersed in a gel. The formulation is administered to an area such as an open wound having an orthopedic implant therein and provides a therapeutically effective level of drug to the patient over therapeutically effective period of time.</p><script id="control-dust-server-29949745-6" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-6","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-6";}</script></div></div><div id="patent-77" class="editable-item section-item"><div id="patent-77-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D2%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=K9gk&trk=prof-patent-title-link" name="patent-site" target="_blank">Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 7,490,603 </h5></hgroup><span class="patents-date">Issued&nbsp;February 17, 2009</span><p class="description summary-field-show-more">The need for the delivery of insulin by injection can be reduced or eliminated by delivering an aerosolized monomeric insulin formulation. Repeatability of dosing and more particularly the repeatability of the blood concentration versus time profile is improved relative to regular insulin. The blood concentration versus time profile is substantially unaffected by specific aspects of the patient&#39;s breathing maneuver at delivery. Further, the rate at which blood glucose is lowered is increased by the use of monomeric insulin. Particles of insulin and in particular monomeric insulin delivered to the surface of lung tissue will be absorbed into the circulatory system. The monomeric insulin may be a dry powder but is preferably in a liquid formulation delivered to the patient from a hand-held, self-contained device which automatically releases an aerosolized burst of formulation. The device includes a sensor which is preferably electronic which measures inspiratory flow and volume which measurement can be used to control the point of drug release.</p><script id="control-dust-server-29949745-7" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-7","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-7";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-81" class="editable-item section-item"><div id="patent-81-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D4%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=pEOT&trk=prof-patent-title-link" name="patent-site" target="_blank">Method of treating diabetes mellitus in a patient<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 7,448,375 </h5></hgroup><span class="patents-date">Issued&nbsp;November 11, 2008</span><p class="description summary-field-show-more">Dosages of inhaled insulin are controlled within a narrow range by controlling the total volume of air inhaled by a patient. By repeatedly delivering aerosolized insulin with the same total inhaled volume of air, the amount of insulin delivered to the patient each time is consistent. A device for delivering insulin by inhalation is disclosed which device comprises a means for measuring inhaled volume and for halting inhalation at a pre-determined point. The device also comprises an adjustable means for applying various amounts of force to a container of formulation to expel different amounts of drug from the container based on the force applied.</p><script id="control-dust-server-29949745-8" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-8","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-8";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-85" class="editable-item section-item"><div id="patent-85-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D4%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=pEOT&trk=prof-patent-title-link" name="patent-site" target="_blank">Method of treating diabetes mellitus in a patient<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 7,448,375 </h5></hgroup><span class="patents-date">Issued&nbsp;November 11, 2008</span><p class="description summary-field-show-more">Dosages of inhaled insulin are controlled within a narrow range by controlling the total volume of air inhaled by a patient. By repeatedly delivering aerosolized insulin with the same total inhaled volume of air, the amount of insulin delivered to the patient each time is consistent. A device for delivering insulin by inhalation is disclosed which device comprises a means for measuring inhaled volume and for halting inhalation at a pre-determined point. The device also comprises an adjustable means for applying various amounts of force to a container of formulation to expel different amounts of drug from the container based on the force applied.</p><script id="control-dust-server-29949745-9" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-9","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-9";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-89" class="editable-item section-item"><div id="patent-89-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D5%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=9X5I&trk=prof-patent-title-link" name="patent-site" target="_blank">Method for treating diabetes mellitus in a patient<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 7,278,419 </h5></hgroup><span class="patents-date">Issued</span><p class="description summary-field-show-more">The need for the delivery of insulin by injection can be reduced or eliminated by delivering aerosolized insulin. Repeatability of dosing is obtainable by using either regular insulin or monomeric insulin. When delivering insulin (not monomeric) by inhalation, the total inhaled volume should be about the same at each delivery to obtain repeatable results. The patient can be coached (by teaching) to inhale a given amount of air and can also be coached (by teaching) to inhale at a given flow rate. Further, the rate at which blood glucose is lowered is increased by the use of monomeric insulin. Particles of insulin and monomeric insulin delivered to the surface of lung tissue will be absorbed into the circulatory system. A dry powder or a liquid insulin formulation is delivered to the patient from a mechanical or electronic hand-held, self-contained device.</p><script id="control-dust-server-29949745-10" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-10","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-10";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-93" class="editable-item section-item"><div id="patent-93-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D6%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=ESBP&trk=prof-patent-title-link" name="patent-site" target="_blank">Methods and compositions for treating erectile dysfunction<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 7,258,850 </h5></hgroup><span class="patents-date">Issued&nbsp;August 21, 2007</span><p class="description summary-field-show-more">Methods are provided for increasing libido and/or treating erectile dysfunction in a man. The methods include the administration of a formulation testosterone alone, another fast-acting drug to treat erectile dysfunction or a combination of the testosterone and the other drug where at least one is delivered by aersolization. The formulation is preferably aerosolized and inhaled into a patient&#39;s lungs where particles of testosterone and/or the fast-acting erectile dysfunction drug deposits on lung tissue and then enter the patient&#39;s circulatory system.</p><script id="control-dust-server-29949745-11" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-11","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-11";}</script><dl class="associated-list education-associated associated-condensed"><dt>Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/robert-cole-m-d/15/490/2a8">Robert Cole, M.D.</a>, </li><li>James Blanchard, </li><li>Jeffrey Schuster, </li><li>Lawrence Linn, </li><li>John Tipphawong</li></ul></dd></dl></div></div><div id="patent-100" class="editable-item section-item"><div id="patent-100-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D8%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=NR1J&trk=prof-patent-title-link" name="patent-site" target="_blank">Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 7,028,686 </h5></hgroup><span class="patents-date">Issued&nbsp;April 18, 2006</span><p class="description summary-field-show-more">Dosages of inhaled insulin are controlled within a narrow range by controlling the total volume of air inhaled by a patient. By repeatedly delivering aerosolized insulin with the same total inhaled volume of air, the amount of insulin delivered to the patient each time is consistent. A device for delivering insulin by inhalation is disclosed which device comprises a means for measuring inhaled volume and for halting inhalation at a pre-determined point. The device also comprises an adjustable means for applying various amounts of force to a container of formulation to expel different amounts of drug from the container based on the force applied.</p><script id="control-dust-server-29949745-12" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-12","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-12";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-104" class="editable-item section-item"><div id="patent-104-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D9%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=dtDj&trk=prof-patent-title-link" name="patent-site" target="_blank">Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 7,021,309 </h5></hgroup><span class="patents-date">Issued&nbsp;April 4, 2006</span><p class="description summary-field-show-more">The need for the delivery of insulin by injection can be reduced or eliminated by delivering an aerosolized monomeric insulin formulation. Repeatability of dosing and more particularly the repeatability of the blood concentration versus time profile is improved relative to regular insulin. The blood concentration versus time profile is substantially unaffected by specific aspects of the patient&#39;s breathing maneuver at delivery. Further, the rate at which blood glucose is lowered is increased by the use of monomeric insulin. Particles of insulin and in particular monomeric insulin delivered to the surface of lung tissue will be absorbed into the circulatory system. The monomeric insulin may be a dry powder but is preferably in a liquid formulation delivered to the patient from a hand-held, self-contained device which automatically releases an aerosolized burst of formulation. The device includes a sensor which is preferably electronic which measures inspiratory flow and volume which measurement can be used to control the point of drug release.</p><script id="control-dust-server-29949745-13" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-13","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-13";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-108" class="editable-item section-item"><div id="patent-108-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D11%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=TBNM&trk=prof-patent-title-link" name="patent-site" target="_blank">Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,688,304 </h5></hgroup><span class="patents-date">Issued&nbsp;February 10, 2004</span><p class="description summary-field-show-more">Dosages of inhaled insulin are controlled within a narrow range by controlling the total volume of air inhaled by a patient. By repeatedly delivering aerosolized insulin with the same total inhaled volume of air, the amount of insulin delivered to the patient each time is consistent. A device for delivering insulin by inhalation is disclosed which device comprises a means for measuring inhaled volume and for halting inhalation at a pre-determined point. The device also comprises an adjustable means for applying various amounts of force to a container of formulation to expel different amounts of drug from the container based on the force applied.</p><script id="control-dust-server-29949745-14" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-14","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-14";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-112" class="editable-item section-item"><div id="patent-112-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D12%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=T-Uk&trk=prof-patent-title-link" name="patent-site" target="_blank">Insulin delivery enhanced by coached breathing<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,647,987 </h5></hgroup><span class="patents-date">Issued&nbsp;February 18, 2003</span><p class="description summary-field-show-more">The need for the delivery of insulin by injection can be reduced or eliminated by a method whereby an aerosolized insulin formulation is delivered to a patient&#39;s lungs and the rate at which the insulin is absorbed into the blood is increased by the use of an inhale-exhale breathing maneuver. Particles of insulin delivered to the surface of lung tissue will be absorbed into the circulatory system. The rate of absorption is enhanced by instructing the patient to inhale maximally and thereafter exhale maximally. The insulin is delivered to the patient from a hand-held, self-contained device which automatically releases an aerosolized burst of formulation. The device includes a sensor which is preferably electronic which measures inspiratory flow and volume which measurement can be used to control the point of drug release. The sensor can also assist the patient in the inhale-exhale maneuver.</p><script id="control-dust-server-29949745-15" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-15","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-15";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-116" class="editable-item section-item"><div id="patent-116-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D13%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=2MuT&trk=prof-patent-title-link" name="patent-site" target="_blank">Increasing libido in humans via acute testosterone administration<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,632,419 </h5></hgroup><span class="patents-date">Issued&nbsp;October 14, 2003</span><p class="description summary-field-show-more">The libido of adult human female patients is increased by the bolus delivery of a testosterone which is preferably dihydrotestosterone. The formulation is preferably aerosolized and inhaled into a patient&#39;s lungs where particles of testosterone deposits on lung tissue and then enter the patient&#39;s circulatory system. The patient&#39;s testosterone level is quickly enhanced well above baseline levels for a short period and subsides to baseline levels with normal metabolism thereby providing desired short term effects on enhanced libido without undesirable effects of long term enhanced testosterone levels. Additional formulations are provided including formulations for aerosolized delivery of sildenafil citrate which are delivered to male or female patients.</p><script id="control-dust-server-29949745-16" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-16","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-16";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/robert-cole-m-d/15/490/2a8">Robert Cole, M.D.</a></li></ul></dd></dl></div></div><div id="patent-119" class="editable-item section-item"><div id="patent-119-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D14%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=UIYv&trk=prof-patent-title-link" name="patent-site" target="_blank">Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,431,167 </h5></hgroup><span class="patents-date">Issued&nbsp;August 13, 2002</span><p class="description summary-field-show-more">The need for the delivery of insulin by injection can be reduced or eliminated by delivering an aerosolized monomeric insulin formulation. Repeatability of dosing and more particularly the repeatability of the blood concentration versus time profile is improved relative to regular insulin. The blood concentration versus time profile is substantially unaffected by specific aspects of the patient&#39;s breathing maneuver at delivery. Further, the rate at which blood glucose is lowered is increased by the use of monomeric insulin. Particles of insulin and in particular monomeric insulin delivered to the surface of lung tissue will be absorbed into the circulatory system. The monomeric insulin may be a dry powder but is preferably in a liquid formulation delivered to the patient from a hand-held, self-contained device which automatically releases an aerosolized burst of formulation. The device includes a sensor which is preferably electronic which measures inspiratory flow and volume which measurement can be used to control the point of drug release.</p><script id="control-dust-server-29949745-17" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-17","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-17";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-123" class="editable-item section-item"><div id="patent-123-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D15%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=g4r8&trk=prof-patent-title-link" name="patent-site" target="_blank">Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,431,166 </h5></hgroup><span class="patents-date">Issued&nbsp;August 13, 2002</span><p class="description summary-field-show-more">The need for the delivery of insulin by injection can be reduced or eliminated by delivering an aerosolized monomeric insulin formulation. Repeatability of dosing and more particularly the repeatability of the blood concentration versus time profile is improved relative to regular insulin. The blood concentration versus time profile is substantially unaffected by specific aspects of the patient&#39;s breathing maneuver at delivery. Further, the rate at which blood glucose is lowered is increased by the use of monomeric insulin. Particles of insulin and in particular monomeric insulin delivered to the surface of lung tissue will be absorbed into the circulatory system. The monomeric insulin may be a dry powder but is preferably in a liquid formulation delivered to the patient from a hand-held, self-contained device which automatically releases an aerosolized burst of formulation. The device includes a sensor which is preferably electronic which measures inspiratory flow and volume which measurement can be used to control the point of drug release.</p><script id="control-dust-server-29949745-18" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-18","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-18";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-127" class="editable-item section-item"><div id="patent-127-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D16%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=t5_a&trk=prof-patent-title-link" name="patent-site" target="_blank">Acute testosterone administration<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,428,769 </h5></hgroup><span class="patents-date">Issued&nbsp;August 6, 2002</span><p class="description summary-field-show-more">The libido of adult human female patients is increased by the intrapulmonary delivery of testosterone. A formulation of testosterone is aerosolized and inhaled into a patient&#39;s lungs where particles of testosterone deposits on lung tissue and then enter the patient&#39;s circulatory system. The patient&#39;s testosterone level is enhanced well above baseline levels for a short period and subsides to baseline levels with normal metabolism thereby providing desired short term effects on enhanced libido without undesirable effects of long term enhanced testosterone levels. Additional formulations are provided including formulations for aerosolized delivery of sildenafil citrate which are delivered to male or female patients.</p><script id="control-dust-server-29949745-19" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-19","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-19";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/robert-cole-m-d/15/490/2a8">Robert Cole, M.D.</a></li></ul></dd></dl></div></div><div id="patent-130" class="editable-item section-item"><div id="patent-130-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D17%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=xnfg&trk=prof-patent-title-link" name="patent-site" target="_blank">Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,427,681 </h5></hgroup><span class="patents-date">Issued&nbsp;August 6, 2002</span><p class="description summary-field-show-more">The need for the delivery of insulin by injection can be reduced or eliminated by delivering an aerosolized monomeric insulin formulation. Repeatability of dosing and more particularly the repeatability of the blood concentration versus time profile is improved relative to regular insulin. The blood concentration versus time profile is substantially unaffected by specific aspects of the patient&#39;s breathing maneuver at delivery. Further, the rate at which blood glucose is lowered is increased by the use of monomeric insulin. Particles of insulin and in particular monomeric insulin delivered to the surface of lung tissue will be absorbed into the circulatory system. The monomeric insulin may be a dry powder but is preferably in a liquid formulation delivered to the patient from a hand-held, self-contained device which automatically releases an aerosolized burst of formulation. The device includes a sensor which is preferably electronic which measures inspiratory flow and volume which measurement can be used to control the point of drug release.</p><script id="control-dust-server-29949745-20" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-20","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-20";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-134" class="editable-item section-item"><div id="patent-134-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D18%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=OVsv&trk=prof-patent-title-link" name="patent-site" target="_blank">Insulin delivery enhanced by coached breathing<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,408,854 </h5></hgroup><span class="patents-date">Issued&nbsp;June 25, 2002</span><p class="description summary-field-show-more">The need for the delivery of insulin by injection can be reduced or eliminated by a method whereby an aerosolized insulin formulation is delivered to a patient&#39;s lungs and the rate at which the insulin is absorbed into the blood is increased by the use of an inhale-exhale breathing maneuver. Particles of insulin delivered to the surface of lung tissue will be absorbed into the circulatory system. The rate of absorption is enhanced by instructing the patient to inhale maximally and thereafter exhale maximally. This maneuver causes a spike in the rate at which insulin enters the circulatory system thereby increasing the rate at which glucose is removed from the circulatory system. The insulinmay be a dry powder but is preferably in a liquid formulation delivered to the patient from a hand-held, self-contained device which automatically releases an aerosolized burst of formulation. The device includes a sensor which is preferably electronic which measures inspiratory flow and volume which measurement can be used to control the point of drug release. The sensor can also assist the patient in the inhale-exhale maneuver.</p><script id="control-dust-server-29949745-21" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-21","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-21";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a></li></ul></dd></dl></div></div><div id="patent-137" class="editable-item section-item"><div id="patent-137-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D19%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=r7YH&trk=prof-patent-title-link" name="patent-site" target="_blank">Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,250,298 </h5></hgroup><span class="patents-date">Issued&nbsp;June 26, 2001</span><p class="description summary-field-show-more">The need for the delivery of insulin by injection can be reduced or eliminated by delivering an aerosolized monomeric insulin formulation. Repeatability of dosing and more particularly the repeatability of the blood concentration versus time profile is improved relative to regular insulin. The blood concentration versus time profile is substantially unaffected by specific aspects of the patient&#39;s breathing maneuver at delivery. Further, the rate at which blood glucose is lowered is increased by the use of monomeric insulin. Particles of insulin and in particular monomeric insulin delivered to the surface of lung tissue will be absorbed into the circulatory system. The monomeric insulin may be a dry powder but is preferably in a liquid formulation delivered to the patient from a hand-held, self-contained device which automatically releases an aerosolized burst of formulation. The device includes a sensor which is preferably electronic which measures inspiratory flow and volume which measurement can be used to control the point of drug release.</p><script id="control-dust-server-29949745-22" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-22","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-22";}</script></div></div><div id="patent-139" class="editable-item section-item"><div id="patent-139-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D22%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=Kx3m&trk=prof-patent-title-link" name="patent-site" target="_blank">Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,167,880 </h5></hgroup><span class="patents-date">Issued&nbsp;January 2, 2001</span><p class="description summary-field-show-more">Dosages of inhaled insulin are controlled within a narrow range by controlling the total volume of air inhaled by a patient. By repeatedly delivering aerosolized insulin with the same total inhaled volume of air, the amount of insulin delivered to the patient each time is consistent. A device for delivering insulin by inhalation is disclosed which device comprises a means for measuring inhaled volume and for halting inhalation at a pre-determined point. The device also comprises an adjustable means for applying various amounts of force to a container of formulation to expel different amounts of drug from the container based on the force applied.</p><script id="control-dust-server-29949745-23" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-23","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-23";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-143" class="editable-item section-item"><div id="patent-143-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D23%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=BhTx&trk=prof-patent-title-link" name="patent-site" target="_blank">Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,131,567 </h5></hgroup><span class="patents-date">Issued&nbsp;October 17, 2000</span><p class="description summary-field-show-more">The need for the delivery of insulin by injection can be reduced or eliminated by delivering an aerosolized monomeric insulin formulation. Repeatability of dosing and more particularly the repeatability of the blood concentration versus time profile is improved relative to regular insulin. The blood concentration versus time profile is substantially unaffected by specific aspects of the patient&#39;s breathing maneuver at delivery. Further, the rate at which blood glucose is lowered is increased by the use of monomeric insulin. Particles of insulin and in particular monomeric insulin delivered to the surface of lung tissue will be absorbed into the circulatory system. The monomeric insulin may be a dry powder but is preferably in a liquid formulation delivered to the patient from a hand-held, self-contained device which automatically releases an aerosolized burst of formulation. The device includes a sensor which is preferably electronic which measures inspiratory flow and volume which measurement can be used to control the point of drug release.</p><script id="control-dust-server-29949745-24" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-24","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-24";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-147" class="editable-item section-item"><div id="patent-147-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D24%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=SHIH&trk=prof-patent-title-link" name="patent-site" target="_blank">Systems for the intrapulmonary delivery of aerosolized aqueous formulations<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,123,068 </h5></hgroup><span class="patents-date">Issued&nbsp;September 26, 2000</span><p class="description summary-field-show-more">A disposable package, tape, and cassette are provided which makes it possible to hold and disperse therefrom liquid, flowable formulations including aqueous formulations (solutions or dispersions with particles less than 0.25 microns in diameter) of a pharmaceutically active drug. In one embodiment formulation is packaged in individual dosage unit containers which containers are preferably interconnected. The package is designed to be integrated into a cassette which can be loaded into a dispersing device capable of individually opening dosage unit containers and aerosolizing the contents through a porous membrane, into a mouth piece on the cassette, for delivery to a patient. In addition to and alongside of each porous membrane, the package may include one or more openings through which air is forced in order to aid in avoiding the accumulation of aerosolized particles. The package may be configured so that the formulation is held in a container not positioned directly vertical to and below the porous membrane, thus making it necessary to channel formulation horizontally to the porous membrane and making it possible to include a vibrating mechanism directly below a chamber covered by the porous membrane. Release of aerosolized drug is breath actuated based on simultaneous measurements of inspiratory flow and volume so as to provide for repeatable dosing of drug to the patient.</p><script id="control-dust-server-29949745-25" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-25","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-25";}</script><dl class="associated-list education-associated associated-condensed"><dt>Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/peter-lloyd/a/829/480">Peter Lloyd</a>, </li><li>Lester John Lloyd, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/jeffrey-schuster/0/a15/335">Jeffrey Schuster</a></li></ul></dd></dl></div></div><div id="patent-152" class="editable-item section-item"><div id="patent-152-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D25%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=r_TV&trk=prof-patent-title-link" name="patent-site" target="_blank">Device for aerosolizing narcotics<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,098,620 </h5></hgroup><span class="patents-date">Issued&nbsp;August 8, 2000</span><p class="description summary-field-show-more">Devices, packaging and methodology for efficiently and repeatably creating aerosolized bursts of an analgesic (e.g., narcotic) containing formulation are disclosed. Devices are hand-held, self-contained units which are automatically actuated at the same release point in a patient&#39;s inspiratory flow cycle. The release point is automatically determined either mechanically or, more preferably calculated by a microprocessor which receives data from a sensor making it possible to determine inspiratory flow rate and inspiratory volume. The device is loaded with a cassette comprised of an outer housing which holds a package of individual disposable collapsible containers of an analgesic containing formulation for systemic delivery. Actuation of the device forces analgesic formulation through a porous membrane of the container which membrane has pores having a diameter in the range of about 0.25 to 3.0 microns, preferably 0.25 to 1.5 microns. The porous membrane is positioned in alignment with a surface of a channel through which a patient inhales air. The flow profile of air moving through the channel is such that the flow at the surface of the channel is less than the flow rate at the center of the channel.</p><script id="control-dust-server-29949745-26" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-26","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-26";}</script><dl class="associated-list education-associated associated-condensed"><dt>Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Peter Lloyd, </li><li>Lester John Lloyd, </li><li>Jeffrey Schuster</li></ul></dd></dl></div></div><div id="patent-157" class="editable-item section-item"><div id="patent-157-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D26%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=ytJB&trk=prof-patent-title-link" name="patent-site" target="_blank">Method of reproducibly effecting a patient&#39;s glucose level<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,098,615 </h5></hgroup><span class="patents-date">Issued&nbsp;August 8, 2000</span><p class="description summary-field-show-more">Devices, packaging and methodology for efficiently and repeatably creating aerosolized bursts of an insulin containing formulation are disclosed. Devices are hand-held, self-contained units which are automatically actuated at the same release point in a patient&#39;s inspiratory flow cycle. The release point is automatically determined either mechanically or, more preferably calculated by a microprocessor which receives data from a sensor making it possible to determine inspiratory flow rate and inspiratory volume. The device is loaded with a cassette comprised of an outer housing which holds a package of individual disposable collapsible containers of an insulin containing formulation for systemic delivery. Actuation of the device forces insulin formulation through a porous membrane of the container which membrane has pores having a diameter in the range of about 0.25 to 3.0 microns, preferably 0.25 to 1.5 microns. The porous membrane is positioned in alignment with a surface of a channel through which a patient inhales air. The flow profile of air moving through the channel is such that the flow at the surface of the channel is less than the flow rate at the center of the channel.</p><script id="control-dust-server-29949745-27" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-27","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-27";}</script><dl class="associated-list education-associated associated-condensed"><dt>Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Lester John Lloyd, </li><li>Peter Lloyd, </li><li>Jeffrey Schuster</li></ul></dd></dl></div></div><div id="patent-162" class="editable-item section-item"><div id="patent-162-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D26%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=ytJB&trk=prof-patent-title-link" name="patent-site" target="_blank">Method of reproducibly effecting a patient&#39;s glucose level<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,098,615 </h5></hgroup><span class="patents-date">Issued&nbsp;August 8, 2000</span><p class="description summary-field-show-more">Devices, packaging and methodology for efficiently and repeatably creating aerosolized bursts of an insulin containing formulation are disclosed. Devices are hand-held, self-contained units which are automatically actuated at the same release point in a patient&#39;s inspiratory flow cycle. The release point is automatically determined either mechanically or, more preferably calculated by a microprocessor which receives data from a sensor making it possible to determine inspiratory flow rate and inspiratory volume. The device is loaded with a cassette comprised of an outer housing which holds a package of individual disposable collapsible containers of an insulin containing formulation for systemic delivery. Actuation of the device forces insulin formulation through a porous membrane of the container which membrane has pores having a diameter in the range of about 0.25 to 3.0 microns, preferably 0.25 to 1.5 microns. The porous membrane is positioned in alignment with a surface of a channel through which a patient inhales air. The flow profile of air moving through the channel is such that the flow at the surface of the channel is less than the flow rate at the center of the channel.</p><script id="control-dust-server-29949745-28" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-28","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-28";}</script><dl class="associated-list education-associated associated-condensed"><dt>Inventors:</dt><dd class="associated-endorsements"><ul><li>Lester John Lloyd, </li><li>Peter Lloyd, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Jeffrey Schuster</li></ul></dd></dl></div></div><div id="patent-167" class="editable-item section-item"><div id="patent-167-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D27%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=fXpi&trk=prof-patent-title-link" name="patent-site" target="_blank">Insulin delivery enhanced by coached breathing<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,085,753 </h5></hgroup><span class="patents-date">Issued&nbsp;July 11, 2000</span><p class="description summary-field-show-more">The need for the delivery of insulin by injection can be reduced or eliminated by a method whereby an aerosolized insulin formulation is delivered to a patient&#39;s lungs and the rate at which the insulin is absorbed into the blood is increased by the use of an inhale-exhale breathing maneuver. Particles of insulin delivered to the surface of lung tissue will be absorbed into the circulatory system. The rate of absorption is enhanced by instructing the patient to inhale maximally and thereafter exhale maximally. This maneuver causes a spike in the rate at which insulin enters the circulatory system thereby increasing the rate at which glucose is removed from the circulatory system. The insulin may be a dry powder but is preferably in a liquid formulation delivered to the patient from a hand-held, self-contained device which automatically releases an aerosolized burst of formulation. The device includes a sensor which is preferably electronic which measures inspiratory flow and volume which measurement can be used to control the point of drug release. The sensor can also assist the patient in the inhale-exhale maneuver.</p><script id="control-dust-server-29949745-29" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-29","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-29";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a></li></ul></dd></dl></div></div><div id="patent-170" class="editable-item section-item"><div id="patent-170-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D29%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=3emq&trk=prof-patent-title-link" name="patent-site" target="_blank">Method of treating a diabetic patient by aerosolized administration of insulin lispro<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,024,090 </h5></hgroup><span class="patents-date">Issued&nbsp;February 15, 2000</span><p class="description summary-field-show-more">The need for the delivery of insulin by injection can be reduced or eliminated by delivering an aerosolized monomeric insulin formulation. Repeatability of dosing and more particularly the repeatability of the blood concentration versus time profile is improved relative to regular insulin. The blood concentration versus time profile is substantially unaffected by specific aspects of the patient&#39;s breathing maneuver at delivery. Further, the rate at which blood glucose is lowered is increased by the use of monomeric insulin. Particles of insulin and in particular monomeric insulin delivered to the surface of lung tissue will be absorbed into the circulatory system. The monomeric insulin may be a dry powder but is preferably in a liquid formulation delivered to the patient from a handheld, self-contained device which automatically releases an aerosolized burst of formulation. The device includes a sensor which is preferably electronic which measures inspiratory flow and volume which measurement can be used to control the point of drug release.</p><script id="control-dust-server-29949745-30" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-30","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-30";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li>Igor Gonda, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-174" class="editable-item section-item"><div id="patent-174-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D30%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=jLfO&trk=prof-patent-title-link" name="patent-site" target="_blank">Disposable package for use in aerosolized delivery of antibiotics<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,014,969 </h5></hgroup><span class="patents-date">Issued&nbsp;January 18, 2000</span><p class="description summary-field-show-more">A disposable package, tape, and cassette are provided which makes it possible to hold and disperse therefrom liquid, flowable formulations including aqueous formulations (solutions or dispersions with particles less than 0.25 microns in diameter) of a pharmaceutically active drug. In one embodiment formulation is packaged in individual dosage unit containers which containers are preferably interconnected. The package is designed to be integrated into a cassette which can be loaded into a dispersing device capable of individually opening dosage unit containers and aerosolizing the contents through a porous membrane, into a mouth piece on the cassette, for delivery to a patient. In addition to and alongside of each porous membrane, the package may include one or more openings through which air is forced in order to aid in avoiding the accumulation of aerosolized particles. The package may be configured so that the formulation is held in a container not positioned directly vertical to and below the porous membrane, thus making it necessary to channel formulation horizontally to the porous membrane and making it possible to include a vibrating mechanism directly below a chamber covered by the porous membrane. Release of aerosolized drug is breath actuated based on simultaneous measurements of inspiratory flow and volume so as to provide for repeatable dosing of drug to the patient.</p><script id="control-dust-server-29949745-31" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-31","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-31";}</script><dl class="associated-list education-associated associated-condensed"><dt>Inventors:</dt><dd class="associated-endorsements"><ul><li>Lester John Lloyd, </li><li>Peter Lloyd, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Jeffrey Schuster</li></ul></dd></dl></div></div><div id="patent-179" class="editable-item section-item"><div id="patent-179-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D31%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=omJ8&trk=prof-patent-title-link" name="patent-site" target="_blank">Intrapulmonary delivery of hematopoietic drug<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 6,012,450 </h5></hgroup><span class="patents-date">Issued&nbsp;January 11, 2000</span><p class="description summary-field-show-more">A method of treating human patients is provided by the intrapulmonary delivery of a formulation containing a hematopoietic drug. The formulation is automatically released in an aerosolized form from a hand-held, self-contained, portable device comprised of a means for automatically releasing a measured amount of drug into the inspiratory flow path of a patient in response to information obtained from a means for measuring the inspiratory flow rate and determining the inspiratory volume of a patient. Reproducible dosing is obtained by providing for automatic release at the same inspiratory flow rate and inspiratory volume each time drug is released. The device includes a timer to enable a patient to take a drug at the same time each day. Further, overadministration of a hematopoietic drug formulation is avoided by providing a pre-programmed microprocessor designed to avoid overdosing.<br>
</p><script id="control-dust-server-29949745-32" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-32","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-32";}</script></div></div><div id="patent-181" class="editable-item section-item"><div id="patent-181-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D32%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=Z0pa&trk=prof-patent-title-link" name="patent-site" target="_blank">Method of delivering insulin lispro<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,970,973 </h5></hgroup><span class="patents-date">Issued&nbsp;October 26, 1999</span><p class="description summary-field-show-more">The need for the delivery of insulin by injection can be reduced or eliminated by a method whereby an aerosolized insulin formulation is delivered to a patient&#39;s lungs and the rate at which the insulin is absorbed into the blood is increased by the use of monomeric insulin and/or an inhale-exhale breathing maneuver. Particles of insulin and in particular monomeric insulin delivered to the surface of lung tissue will be absorbed into the circulatory system. The rate of absorption is enhanced by the monomeric form of insulin and by instructing the patient to inhale maximally and thereafter exhale maximally. This maneuver causes a spike in the rate at which insulin enters the circulatory system thereby increasing the rate at which glucose is removed from the circulatory system. The insulin or insulin analog may be a dry powder but is preferably in a liquid formulation delivered to the patient from a hand-held, self-contained device which automatically releases an aerosolized burst of formulation. The device includes a sensor which is preferably electronic which measures inspiratory flow and volume which measurement can be used to control the point of drug release. The sensor can also assist the patient in the inhale-exhale maneuver.</p><script id="control-dust-server-29949745-33" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-33","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-33";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a></li></ul></dd></dl></div></div><div id="patent-184" class="editable-item section-item"><div id="patent-184-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D34%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=q2c3&trk=prof-patent-title-link" name="patent-site" target="_blank">Device for aerosolized delivery of peptide drugs<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,960,792 </h5></hgroup><span class="patents-date">Issued&nbsp;October 5, 1999</span><p class="description summary-field-show-more">A method of treating human patients is provided by the intrapulmonary delivery of a pharmaceutically active peptide formulation. The formulation is automatically released in an aerosolized form from a hand-held, self-contained, portable device comprised of a means for automatically releasing a measured amount of drug into the inspiratory flow path of a patient in response to information obtained from a means for measuring the inspiratory flow rate and determining the inspiratory volume of a patient. Reproducible dosing is obtained by providing for automatic release at the same inspiratory flow rate and inspiratory volume each time drug is released. The device includes a timer to enable a patient to take a drug at the same time each day. Further, overadministration of hormone formulations is avoided by providing a pre-programmed microprocessor designed to avoid overdosing.</p><script id="control-dust-server-29949745-34" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-34","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-34";}</script><dl class="associated-list education-associated associated-condensed"><dt>Inventors:</dt><dd class="associated-endorsements"><ul><li>Lester John Lloyd, </li><li>Peter Lloyd, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Jeffrey Schster</li></ul></dd></dl></div></div><div id="patent-189" class="editable-item section-item"><div id="patent-189-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D35%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=eh5g&trk=prof-patent-title-link" name="patent-site" target="_blank">Dynamic particle size control for aerosolized drug delivery<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,957,124 </h5></hgroup><span class="patents-date">Issued&nbsp;September 28, 1999</span><p class="description summary-field-show-more">Devices, packaging and methodology for creating aerosols are provided which allow for efficient and repeatable delivery of drugs to the lungs of a patient. Devices are hand-held, self-contained units which are automatically actuated at the same release point in a patient&#39;s inspiratory flow cycle. The release point is calculated by a microprocessor which receives data from a sensor making it possible to determine inspiratory flow rate and inspiratory volume. The device is loaded with a cassette comprised of an outer housing which holds a package of individual collapsible containers of pharmaceutically active drug. Actuation of the device forces drug through a porous membrane of the container which membrane has pores having a diameter in the range of about 0.25 to 6.0 microns. The porous membrane is positioned in alignment with a surface of a channel through which a patient inhales air. The flow profile of air moving through the channel is such that the flow at the surface of the channel, and thus the surface of the porous membrane is slow. The membrane is designed in a flexible manner so that when drug formulation is forced against and through the membrane the membrane protrudes outward beyond the flow boundary layer of the channel into faster moving air.<br>
</p><script id="control-dust-server-29949745-35" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-35","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-35";}</script><dl class="associated-list education-associated associated-condensed"><dt>Inventors:</dt><dd class="associated-endorsements"><ul><li>Lester John Lloyd, </li><li>Peter Lloyd, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Jeffrey Schuster</li></ul></dd></dl></div></div><div id="patent-194" class="editable-item section-item"><div id="patent-194-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D36%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=kiKQ&trk=prof-patent-title-link" name="patent-site" target="_blank">Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,941,240 </h5></hgroup><span class="patents-date">Issued&nbsp;August 24, 1999</span><p class="description summary-field-show-more">Dosages of inhaled insulin are controlled within a narrow range by controlling the total volume of air inhaled by a patient. By repeatedly delivering aerosolized insulin with the same total inhaled volume of air, the amount of insulin delivered to the patient each time is consistent. A device for delivering insulin by inhalation is disclosed which device comprises a means for measuring inhaled volume and for halting inhalation at a pre-determined point. The device also comprises an adjustable means for applying various amounts of force to a container of formulation to expel different amounts of drug from the container based on the force applied.</p><script id="control-dust-server-29949745-36" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-36","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-36";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-198" class="editable-item section-item"><div id="patent-198-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D37%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=k_kl&trk=prof-patent-title-link" name="patent-site" target="_blank">Device and method of creating aerosolized mist of respiratory drug<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,934,272 </h5></hgroup><span class="patents-date">Issued&nbsp;August 10, 1999</span><p class="description summary-field-show-more">Devices, packaging and methodology for efficiently and repeatably creating aerosolized bursts of a formulation of respiratory drug are disclosed. Devices are hand-held, self-contained units which are automatically actuated at the same release point in a patient&#39;s inspiratory flow cycle. The release point is automatically determined either mechanically or, more preferably calculated by a microprocessor which receives data from a sensor making it possible to determine inspiratory flow rate and inspiratory volume. The device is loaded with a cassette comprised of an outer housing which holds a package of individual collapsible containers of formulation which comprises a respiratory drug useful in topically treating lung tissue. Actuation of the device forces respiratory drug through a porous membrane of the container which membrane has pores having a diameter in the range of about 0.25 to 6.0 microns. The porous membrane is positioned in alignment with a surface of a channel through which a patient inhales air. The flow profile of air moving through the channel is such that the flow at the surface of the channel is less than the flow rate at the center of the channel. The membrane is designed so that it protrudes outward at all times or is made flexible so that when respiratory drug formulation is forced against and through the membrane the flexible membrane protrudes outward beyond the flow boundary layer of the channel into faster moving air. Because the membrane protrudes into the faster moving air of the channel the particles of aerosol formed are less likely to collide allowing for the formation of a burst of fine aerosol mist with uniform particle size.</p><script id="control-dust-server-29949745-37" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-37","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-37";}</script><dl class="associated-list education-associated associated-condensed"><dt>Inventors:</dt><dd class="associated-endorsements"><ul><li>Lester John Lloyd, </li><li>Peter Lloyd, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Jeffrey Schuster</li></ul></dd></dl></div></div><div id="patent-203" class="editable-item section-item"><div id="patent-203-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D38%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=sHqa&trk=prof-patent-title-link" name="patent-site" target="_blank">Creating an aerosolized formulation of insulin<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,915,378 </h5></hgroup><span class="patents-date">Issued&nbsp;June 29, 1999</span><p class="description summary-field-show-more">Devices, packaging and methodology for efficiently and repeatably creating aerosolized bursts of an insulin containing formulation are disclosed. Devices are hand-held, self-contained units which are automatically actuated at the same release point in a patient&#39;s inspiratory flow cycle. The release point is automatically determined either mechanically or, more preferably calculated by a microprocessor which receives data from a sensor making it possible to determine inspiratory flow rate and inspiratory volume. The device is loaded with a cassette comprised of an outer housing which holds a package of individual disposable collapsible containers of an insulin containing formulation for systemic delivery. Actuation of the device forces insulin formulation through a porous membrane of the container which membrane has pores having a diameter in the range of about 0.25 to 3.0 microns, preferably 0.25 to 1.5 microns. The porous membrane is positioned in alignment with a surface of a channel through which a patient inhales air. The flow profile of air moving through the channel is such that the flow at the surface of the channel is less than the flow rate at the center of the channel. The membrane is designed so that it protrudes outward at all times or made flexible so that when an insulin formulation is forced against and through the membrane the flexible membrane protrudes outward beyond the flow boundary layer of the channel into faster moving air. Because the membrane protrudes into the faster moving air of the channel the particles of aerosol formed are less likely to collide allowing for the formation of a burst of fine aerosol mist with uniform particle size.</p><script id="control-dust-server-29949745-38" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-38","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-38";}</script><dl class="associated-list education-associated associated-condensed"><dt>Inventors:</dt><dd class="associated-endorsements"><ul><li>Lester Lloyd, </li><li>Peter Lloyd, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Jeffrey Schuster</li></ul></dd></dl></div></div><div id="patent-208" class="editable-item section-item"><div id="patent-208-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D39%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=_Hf-&trk=prof-patent-title-link" name="patent-site" target="_blank">Method of intrapulmonary administration of a narcotic drug<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,910,301 </h5></hgroup><span class="patents-date">Issued&nbsp;June 8, 1999</span><p class="description summary-field-show-more">An aerosol formulation of an aerosol propellant and a base form of a narcotic drug selected from the group consisting of fentanyl, sufentanil and remfentanyl is provided. Such a formulation allows for the drug to be dissolved within the propellant and used within a device which does not require the use of a lubricant. Formulations are also disclosed which include lubricants, wherein the lubricant and propellant are both either polar or both non-polar. Thus, the lubricant component does not act as a solvent or cosolvent, but rather acts as a lubricant for the valve used for dispersing the formulation to a patient. Typical non-polar propellants include chlorofluorocarbons, which are typically used in connection with non-polar lubricants such as saturated vegetable oils, e.g. fractionated coconut oils. Typical polar propellants include hydrofluoroalkanes, which are typically used in connection with polar lubricants such as polyethylene glycols.<br>
</p><script id="control-dust-server-29949745-39" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-39","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-39";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a>, </li><li><a href="http://www.linkedin.com/pub/antony-rowe/14/b28/348">Antony Rowe</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a></li></ul></dd></dl></div></div><div id="patent-212" class="editable-item section-item"><div id="patent-212-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D40%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=Wnj7&trk=prof-patent-title-link" name="patent-site" target="_blank">Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,888,477 </h5></hgroup><span class="patents-date">Issued&nbsp;March 30, 1999</span><p class="description summary-field-show-more">The need for the delivery of insulin by injection can be reduced or eliminated by a method whereby an aerosolized insulin formulation is delivered to a patient&#39;s lungs and the rate at which the insulin is absorbed into the blood is increased by the use of monomeric insulin and/or an inhale-exhale breathing maneuver. Particles of insulin and in particular monomeric insulin delivered to the surface of lung tissue will be absorbed into the circulatory system. The rate of absorption is enhanced by the monomeric form of insulin and by instructing the patient to inhale maximally and thereafter exhale maximally. This maneuver causes a spike in the rate at which insulin enters the circulatory system thereby increasing the rate at which glucose is removed from the circulatory system. The insulin or insulin analog may be a dry powder but is preferably in a liquid formulation delivered to the patient from a hand-held, self-contained device which automatically releases an aerosolized burst of formulation. The device includes a sensor which is preferably electronic which measures inspiratory flow and volume which measurement can be used to control the point of drug release. The sensor can also assist the patient in the inhale-exhale maneuver.</p><script id="control-dust-server-29949745-40" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-40","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-40";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-216" class="editable-item section-item"><div id="patent-216-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D41%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=vCIM&trk=prof-patent-title-link" name="patent-site" target="_blank">Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,884,620 </h5></hgroup><span class="patents-date">Issued&nbsp;March 23, 1999</span><p class="description summary-field-show-more">Dosages of inhaled insulin are controlled within a narrow range by controlling the total volume of air inhaled by a patient. By repeatedly delivering aerosolized insulin with the same total inhaled volume of air, the amount of insulin delivered to the patient each time is consistent. A device for delivering insulin by inhalation is disclosed which device comprises a means for measuring inhaled volume and for halting inhalation at a pre-determined point. The device also comprises an adjustable means for applying various amounts of force to a container of formulation to expel different amounts of drug from the container based on the force applied.</p><script id="control-dust-server-29949745-41" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-41","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-41";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-220" class="editable-item section-item"><div id="patent-220-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D42%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=RbcV&trk=prof-patent-title-link" name="patent-site" target="_blank">Method of maintaining a diabetic patient&#39;s blood glucose level in a desired range<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,873,358 </h5></hgroup><span class="patents-date">Issued&nbsp;February 23, 1999</span><p class="description summary-field-show-more">The need for the delivery of insulin by injection can be reduced or eliminated by a method whereby an aerosolized insulin formulation is delivered to a patient&#39;s lungs and the rate at which the insulin is absorbed into the blood is increased by the use of monomeric insulin and/or an inhale-exhale breathing maneuver. Particles of insulin and in particular monomeric insulin delivered to the surface of lung tissue will be absorbed into the circulatory system. The rate of absorption is enhanced by the monomeric form of insulin and by instructing the patient to inhale maximally and thereafter exhale maximally. This maneuver causes a spike in the rate at which insulin enters the circulatory system thereby increasing the rate at which glucose is removed from the circulatory system. The insulin or insulin analog may be a dry powder but is preferably in a liquid formulation delivered to the patient from a hand-held, self-contained device which automatically releases an aerosolized burst of formulation. The device includes a sensor which is preferably electronic which measures inspiratory flow and volume which measurement can be used to control the point of drug release. The sensor can also assist the patient in the inhale-exhale maneuver.</p><script id="control-dust-server-29949745-42" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-42","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-42";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a></li></ul></dd></dl></div></div><div id="patent-223" class="editable-item section-item"><div id="patent-223-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D44%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=dINy&trk=prof-patent-title-link" name="patent-site" target="_blank">Ventilation imaging using a fine particle aerosol generator<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,829,436 </h5></hgroup><span class="patents-date">Issued&nbsp;November 3, 1998</span><p class="description summary-field-show-more">A method of diagnosing a patient is carried out by delivering an aerosolized dose of a radioactive formulation to a patient and making a ventilation image of radioactive material deposited in the lung. This image is compared with a separately generated image (perfusion image) taken after injecting radiolabled particles into the pulmonary arterial circulation. Devices, packaging and methodology for creating aerosols are provided which allow for efficient and repeatable delivery of radioaerosols to the lungs of a patient. Devices may be plug-in units or hand-held, self-contained units which are automatically actuated at the same release point in a patient&#39;s inspiratory flow cycle. The device is loaded with a container of a radioactive formulation such as .sup.99m Tc-labelled diethylene-triamine pentaacetic acid (DTPA). Actuation of the device forces the radioactive formulation through a porous membrane of the container which membrane has pores having a diameter in the range of about 0.25 to 6.0 microns. The container includes radioactive shielding in the form of a lead coating and/or a lead surrounding packet. The porous membrane is positioned in alignment with a surface of a channel through which a patient inhales air.</p><script id="control-dust-server-29949745-43" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-43","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-43";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a>, </li><li>Fred Silverstein</li></ul></dd></dl></div></div><div id="patent-227" class="editable-item section-item"><div id="patent-227-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D45%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=_soT&trk=prof-patent-title-link" name="patent-site" target="_blank">Prefilter for prevention of clogging of a nozzle in the generation of an aerosol and prevention of administration of undesirable particles<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,829,435 </h5></hgroup><span class="patents-date">Issued&nbsp;November 3, 1998</span><p class="description summary-field-show-more">A device, drug package and methodology for using such to generate an aerosol by moving a flowable formulation through a low resistance filter and then through a nozzle comprised of a porous membrane are disclosed. The package is comprised of a collapsible wall portion that forms a container for holding a liquid formulation which container has an opening covered by a cover portion comprising a nozzle. The membrane pores of the nozzle have a size in the range of 0.25 to 6 microns, preferably 0.5 to 6 microns. A low resistance filter, which is positioned between the flowable formulation and the nozzle, includes openings that are the same size as or smaller than the pores of the nozzle&#39;s porous membrane but includes the openings in an amount and density such that flowable formulation flows through the filter with less resistance than when the formulation moves through the porous membrane. Thus, the filter does not significantly increase the amount of pressure needed to aerosolize the formulation, prevents clogging of the porous membrane of the nozzle by any undesirable particles that may be in the formulation, prevents delivery of any such undesirable particles to the patient, and thereby improves the homogeneity of the aerosol formulation delivered to the patient, as well as the consistency and reproducibility of the aerosolized dose created.</p><script id="control-dust-server-29949745-44" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-44","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-44";}</script><dl class="associated-list education-associated associated-condensed"><dt>Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a>, </li><li><a href="http://www.linkedin.com/pub/david-cipolla/1/541/8b3">David Cipolla</a></li></ul></dd></dl></div></div><div id="patent-232" class="editable-item section-item"><div id="patent-232-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D46%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=1rLf&trk=prof-patent-title-link" name="patent-site" target="_blank">Delivery of aerosol medications for inspiration<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,826,570 </h5></hgroup><span class="patents-date">Issued&nbsp;October 27, 1998</span><p class="description summary-field-show-more">Apparatus and methods for delivering an amount of aerosolized medicine for inspiration by a patient in response to the occurrence of appropriate delivery point or points in the patient&#39;s detected breath flow. The aerosol medication may be administered as one or more pulses having a pulse width, shape, and frequency that will maximize the respirable fraction of the aerosolized compound being administered. The delivery point or points may be predetermined or determined from a prior inspiratory flow for depositing the selected medication at one or more desired locations in the patient&#39;s airway. Determined delivery points are recursively lowered for each inspiratory flow that does not satisfy one of the predetermined and previously lowered threshold. Changes in the patient&#39;s breath flow patterns during the course of an aerosolized medication inspiration therapy program may be detected and used to adjust the controlled amount of medication to be delivered in a given administration and/or to inform the patient of the patient&#39;s condition or change in condition. The device also may contain a library of administration protocols or operating parameters for different medications and a means for identifying from the canister the medicinal contents of the canister for customizing operation of the apparatus.</p><script id="control-dust-server-29949745-45" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-45","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-45";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>David Goodman</li></ul></dd></dl></div></div><div id="patent-235" class="editable-item section-item"><div id="patent-235-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D47%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=lG-J&trk=prof-patent-title-link" name="patent-site" target="_blank">Disposable package for use in aerosolized delivery of drugs<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,823,178 </h5></hgroup><span class="patents-date">Issued&nbsp;October 20, 1998</span><p class="description summary-field-show-more">A disposable package, tape, and cassette are provided which makes it possible to hold and disperse therefrom liquid, flowable formulations including aqueous formulations (solutions or dispersions with particles less than 0.25 microns in diameter) of a pharmaceutically active drug. In one embodiment formulation is packaged in individual dosage unit containers which containers are preferably interconnected. The package is designed to be integrated into a cassette which can be loaded into a dispersing device capable of individually opening dosage unit containers and aerosolizing the contents through a porous membrane, into a mouth piece on the cassette, for delivery to a patient. In addition to and alongside of each porous membrane, the package may include one or more openings through which air is forced in order to aid in avoiding the accumulation of aerosolized particles. The package may be configured so that the formulation is held in a container not positioned directly vertical to and below the porous membrane, thus making it necessary to channel formulation horizontally to the porous membrane and making it possible to include a vibrating mechanism directly below a chamber covered by the porous membrane. Release of aerosolized drug is breath actuated based on simultaneous measurements of inspiratory flow and volume so as to provide for repeatable dosing of drug to the patient.</p><script id="control-dust-server-29949745-46" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-46","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-46";}</script><dl class="associated-list education-associated associated-condensed"><dt>Inventors:</dt><dd class="associated-endorsements"><ul><li>Lester John Lloyd, </li><li>Peter Lloyd, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Jeffrey Schuster</li></ul></dd></dl></div></div><div id="patent-240" class="editable-item section-item"><div id="patent-240-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D48%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=yU64&trk=prof-patent-title-link" name="patent-site" target="_blank">Method for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,819,726 </h5></hgroup><span class="patents-date">Issued&nbsp;October 13, 1998</span><p class="description summary-field-show-more">A method of treating patients suffering from a respiratory disease using a programmable, hand-held, self-contained drug dispensing device is disclosed. A patient&#39;s inspiratory flow rate is measured and a determination is made of a typical and preferred rate and volume for the release of respiratory drug. To obtain repeatability in dosing the drug is repeatedly released at the same rate and volume. To maximize the amount of drug delivered based on the amount released the drug is released at a rate of from about 0.10 to about 2.0 liters/second and (2) a volume of about 0.15 to about 0.8 liters. Parameters such as rate, volume, and particle size of the aerosolized formulation are adjusted to obtain repeatable dosing of the maximum amount of drug to the desired area of the lung. Lung function is measured and use parameters are adjusted in order to improve lung function.</p><script id="control-dust-server-29949745-47" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-47","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-47";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Lester John Lloyd</li></ul></dd></dl></div></div><div id="patent-243" class="editable-item section-item"><div id="patent-243-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D49%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=Uyri&trk=prof-patent-title-link" name="patent-site" target="_blank">Delivery of aerosol medication for inspiration<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,813,397 </h5></hgroup><span class="patents-date">Issued&nbsp;September 29, 1998</span><p class="description summary-field-show-more">Apparatus and methods for delivering an amount of aerosolized medicine for inspiration by a patient in response to the occurrence of appropriate delivery point or points in the patient&#39;s detected breath flow. The aerosol medication may be administered as one or more pulses having a pulse width, shape, and frequency that will maximize the respirable fraction of the aerosolized compound being administered. The delivery point or points may be predetermined or determined from a prior inspiratory flow for depositing the selected medication at one or more desired locations in the patient&#39;s airway. Determined delivery points are recursively lowered for each inspiratory flow that does not satisfy one of the predetermined and previously lowered threshold. Changes in the patient&#39;s breath flow patterns during the course of an aerosolized medication inspiration therapy program may be detected and used to adjust the controlled amount of medication to be delivered in a given administration and/or to inform the patient of the patient&#39;s condition or change in condition. The device also may contain a library of administration protocols or operating parameters for different medications and a means for identifying from the canister the medicinal contents of the canister for customizing operation of the apparatus.</p><script id="control-dust-server-29949745-48" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-48","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-48";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>David Goodman</li></ul></dd></dl></div></div><div id="patent-246" class="editable-item section-item"><div id="patent-246-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D50%26p%3D1%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3Drubsamen%2EINNM%2E%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=qaIh&trk=prof-patent-title-link" name="patent-site" target="_blank">Ventilation imaging using a fine particle aerosol generator<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,792,057 </h5></hgroup><span class="patents-date">Issued&nbsp;August 11, 1998</span><p class="description summary-field-show-more">A method of diagnosing a patient is carried out by delivering an aerosolized dose of a radioactive formulation to a patient and making a ventilation image of radioactive material deposited in the lung. This image is compared with a separately generated image (perfusion image) taken after injecting radiolabled particles into the pulmonary arterial circulation. A diagnosis of a pulmonary embolism can be made when areas of the lung which are shown in the ventilation image are not shown within the perfusion image, indicating that air flow to that area exists, whereas a blood flow to that area has been blocked. Devices, packaging and methodology for creating aerosols are provided which allow for efficient and repeatable delivery of radioaerosols to the lungs of a patient. Devices may be plug-in units or hand-held, self-contained units which are automatically actuated at the same release point in a patient&#39;s inspiratory flow cycle. The release point is automatically determined either mechanically or, more preferably calculated by a microprocessor which receives data from a sensor making it possible to determine inspiratory flow rate and inspiratory volume. The device is loaded with a container of a radioactive formulation such as .sup.99m Tc-labelled diethylene-triamine pentaacetic acid (DTPA). Actuation of the device forces the radioactive formulation through a porous membrane of the container which membrane has pores having a diameter in the range of about 0.25 to 6.0 microns. The container includes radioactive shielding in the form of a lead coating and/or a lead surrounding packet.</p><script id="control-dust-server-29949745-49" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-49","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-49";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/steve-farr/10/19/34b">Steve Farr</a></li></ul></dd></dl></div></div><div id="patent-249" class="editable-item section-item"><div id="patent-249-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D51%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=LXbK&trk=prof-patent-title-link" name="patent-site" target="_blank">Method and apparatus for releasing a controlled amount of aerosol medication over a selectable time interval<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,755,218 </h5></hgroup><span class="patents-date">Issued&nbsp;May 26, 1998</span><p class="description summary-field-show-more">A portable, battery powered, hand-held system for releasing a controlled dose of aerosol medication for inhalation by a patient including a durable body and a medication cassette inserted in the durable body. The cassette includes a housing for containing a canister of medication, bears an identification code, and permits the canister to be manually depressed to release a dose, e.g., a metered dose, when out of the durable body. The durable body includes an actuator mechanism for engaging an inserted cassette and its canister, and an actuator release mechanism for controlling the actuator mechanism to depress the canister for a selected period of time to release the desired dose of medication and then the release the canister. The actuator mechanism, includes a compression spring for depressing the canister and a torsion spring for reloading the compression spring. The torsion spring is reloaded by rotating the cassette from an open position for delivering aerosol to a closed position. The actuator release mechanism includes a motor and trigger pin assembly that controls the release of the compression spring and the torsion spring, and, hence, the time that the canister is depressed. The motor operates in response to sensed flow satisfying a selected delivery threshold. The durable body includes a flow sensor having an asymmetrical orifice that is calibrated, independent of the cassette, to convert the sensed pressure due to flow into a flow rate. The orifice is separately calibrated for an inhalation flow rate range and an exhalation flow rate range over a selected number of known flow rates. The sensed pressure value is corrected for transducer offset drift and converted to a flow rate using the calibration data and piecewise linear interpolation.</p><script id="control-dust-server-29949745-50" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-50","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-50";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Karl Ritson, </li><li><a href="http://www.linkedin.com/pub/eric-johansson/0/17a/136">Eric Johansson</a></li></ul></dd></dl></div></div><div id="patent-253" class="editable-item section-item"><div id="patent-253-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D52%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=8Me7&trk=prof-patent-title-link" name="patent-site" target="_blank">Method for releasing controlled amount of aerosol medication<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,743,252 </h5></hgroup><span class="patents-date">Issued&nbsp;April 28, 1998</span><p class="description summary-field-show-more">A method for releasing a controlled amount of aerosol medication is disclosed. The method of the invention is preferably used in connection with a portable, battery-powered, hand-held system for releasing a controlled dose of aerosol medication for inhalation by a patient. The inhalation breath flow of the user of the apparatus is monitored and the inhalation flow rate is measured, and inhalation volume is determined as a function of the measured flow rate. The measured flow rate is compared to predetermined minimum and maximum flow rate thresholds, and the determined flow volume is compared to predetermined minimum and maximum flow volume thresholds. When both the measured flow rate and the measured flow volume are between their respective the minimum and maximum thresholds, a signal is provided to release a controlled amount of aerosol.</p><script id="control-dust-server-29949745-51" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-51","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-51";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/eric-johansson/0/17a/136">Eric Johansson</a></li></ul></dd></dl></div></div><div id="patent-256" class="editable-item section-item"><div id="patent-256-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D53%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=EPkO&trk=prof-patent-title-link" name="patent-site" target="_blank">Insulin delivery enhanced by coached breathing<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,743,250 </h5></hgroup><span class="patents-date">Issued&nbsp;April 28, 1998</span><p class="description summary-field-show-more">The need for the delivery of insulin by injection can be reduced or eliminated by a method whereby an aerosolized insulin formulation is delivered to a patient&#39;s lungs and the rate at which the insulin is absorbed into the blood is increased by the use of an inhale-exhale breathing maneuver. Particles of insulin delivered to the surface of lung tissue will be absorbed into the circulatory system. The rate of absorption is enhanced by instructing the patient to inhale maximally and thereafter exhale maximally. This maneuver causes a spike in the rate at which insulin enters the circulatory system thereby increasing the rate at which glucose is removed from the circulatory system. The insulin may be a dry powder but is preferably in a liquid formulation delivered to the patient from a hand-held, self-contained device which automatically releases an aerosolized burst of formulation. The device includes a sensor which is preferably electronic which measures inspiratory flow and volume which measurement can be used to control the point of drug release. The sensor can also assist the patient in the inhale-exhale maneuver.</p><script id="control-dust-server-29949745-52" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-52","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-52";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/igor-gonda/16/913/79a">Igor Gonda</a></li></ul></dd></dl></div></div><div id="patent-259" class="editable-item section-item"><div id="patent-259-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D54%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=HRil&trk=prof-patent-title-link" name="patent-site" target="_blank">Lockout device for controlled release of drug from patient-activated dispenser<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,735,263 </h5></hgroup><span class="patents-date">Issued&nbsp;April 7, 1998</span><p class="description summary-field-show-more">A method of controlling access to a drug in an aerosol drug delivery device by an electronic lock and key means is disclosed. Access is limited to the intended user by providing the intended user with a uniquely coded, machine readable key means that matches the unique code of the lock means. Contacting matching lock and key means signals a controlling means to allow use of the device. Specifically, the method is applied to a method of pain control provided by the intrapulmonary delivery of a pharmaceutically active pain relief formulation. The formulation is automatically released from a hand-held, self-contained, portable device comprised of a means for automatically releasing a measured amount of drug into the inspiratory flow path of a patient in response to information obtained from a means for measuring and separately determining inspiratory flow rate and inspiratory volume of a patient. Reproducible dosing is obtained by providing for automatic release in response to a separately measured inspiratory rate and inspiratory volume. To obtain repeatability in dosing the narcotic formulation is repeatedly released at the same measured (1) inspiratory flow rate and (2) inspiratory volume. To maximize the efficiency of the delivery the narcotic formulation is released at (1) a measured inspiratory flow rate in the range of from about 0.10 to about 2.0 liters/second and (2) a measured inspiratory volume in the range of about 0.15 to about 0.8 liters. Abuse of narcotic formulations is avoided by providing a tamper-resistant device which includes a variety of security features including an electronic lock and key means and a pre-programmed microprocessor designed to avoid overdosing.</p><script id="control-dust-server-29949745-53" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-53","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-53";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Lester John Lloyd, </li><li><a href="http://www.linkedin.com/pub/eric-johansson/0/17a/136">Eric Johansson</a></li></ul></dd></dl></div></div><div id="patent-263" class="editable-item section-item"><div id="patent-263-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D56%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=qjgP&trk=prof-patent-title-link" name="patent-site" target="_blank">Disposable package for use in aerosolized delivery of drugs<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,718,222 </h5></hgroup><span class="patents-date">Issued&nbsp;February 17, 1998</span><p class="description summary-field-show-more">A disposable package, tape, and cassette are provided which makes it possible to hold and disperse therefrom liquid, flowable formulations including aqueous formulations (solutions or dispersions with particles less than 0.25 microns in diameter) of a pharmaceutically active drug. In one embodiment formulation is packaged in individual dosage unit containers which containers are preferably interconnected. The package is designed to be integrated into a cassette which can be loaded into a dispersing device capable of individually opening dosage unit containers and aerosolizing the contents through a porous membrane, into a mouth piece on the cassette, for delivery to a patient. In addition to and alongside of each porous membrane, the package may include one or more openings through which air is forced in order to aid in avoiding the accumulation of aerosolized particles. The package may be configured so that the formulation is held in a container not positioned directly vertical to and below the porous membrane, thus making it necessary to channel formulation horizontally to the porous membrane and making it possible to include a vibrating mechanism directly below a chamber covered by the porous membrane. Release of aerosolized drug is breath actuated based on simultaneous measurements of inspiratory flow and volume so as to provide for repeatable dosing of drug to the patient.</p><script id="control-dust-server-29949745-54" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-54","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-54";}</script><dl class="associated-list education-associated associated-condensed"><dt>Inventors:</dt><dd class="associated-endorsements"><ul><li>Lester John Lloyd, </li><li>Peter Lloyd, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Jeffrey Schuster</li></ul></dd></dl></div></div><div id="patent-268" class="editable-item section-item"><div id="patent-268-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D57%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=nAS2&trk=prof-patent-title-link" name="patent-site" target="_blank">Intrapulmonary delivery of aerosolized formulations<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,709,202 </h5></hgroup><span class="patents-date">Issued&nbsp;January 20, 1998</span><p class="description summary-field-show-more">Liquid, flowable formulations including aqueous formulations of a pharmaceutically active drug are packaged in individual dosage unit containers which containers are interconnected to form a cellular array designed to be integrated into a dispensing device capable of individually opening dosage unit containers and aerosolizing the contents through a nozzle for delivery to a patient. The cellular array is comprised of a plurality of containers with each container having an opening(s) thereon from which a drug-containing formulation may be aerosolized. The dispensing device is a hand-held, self-contained, portable device comprised of a means for removing covers from the containers and automatically dispensing the formulation from individual containers, preferably in response to a signal obtained as a result of measuring the inspiratory flow of a patient. The cellular array is loaded into the dispensing device to form a system which can be used in a method of delivering drugs to a patient via the intrapulmonary route. In a preferred embodiment each container includes an opening covered by a membrane having a plurality of pores therein wherein the pores have a diameter of about 0.5 microns to 50 microns and the dispensing device includes a vibrating device which creates a vibration frequency such that formulation forced through the pores is aerosolized to particles having a diameter of about 1 micron to 100 microns.</p><script id="control-dust-server-29949745-55" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-55","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-55";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li>Lester John Lloyd, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Peter Lloyd</li></ul></dd></dl></div></div><div id="patent-272" class="editable-item section-item"><div id="patent-272-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D58%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=A227&trk=prof-patent-title-link" name="patent-site" target="_blank">Lockout device for controlled release of drug from patient-activated dispenser<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,694,919 </h5></hgroup><span class="patents-date">Issued&nbsp;December 9, 1997</span><p class="description summary-field-show-more">A method of controlling access to a drug in an aerosol drug delivery device by an electronic lock and key means is disclosed. Access is limited to the intended user by providing the intended user with a uniquely coded, machine readable key means that matches the unique code of the lock means. Contacting matching lock and key means signals a controlling means to allow use of the device. Specifically, the method is applied to a method of pain control provided by the intrapulmonary delivery of a pharmaceutically active pain relief formulation. The formulation is automatically released from a hand-held, self-contained, portable device comprised of a means for automatically releasing a measured amount of drug into the inspiratory flow path of a patient in response to information obtained from a means for measuring and separately determining inspiratory flow rate and inspiratory volume of a patient. Reproducible dosing is obtained by providing for automatic release in response to a separately measured inspiratory rate and inspiratory volume. To obtain repeatability in dosing the narcotic formulation is repeatedly released at the same measured (1) inspiratory flow rate and (2) inspiratory volume. To maximize the efficiency of the delivery the narcotic formulation is released at (1) a measured inspiratory flow rate in the range of from about 0.10 to about 2.0 liters/second and (2) a measured inspiratory volume in the range of about 0.15 to about 0.8 liters. Abuse of narcotic formulations is avoided by providing a tamper-resistant device which includes a variety of security features including an electronic lock and key means and a pre-programmed microprocessor designed to avoid overdosing.</p><script id="control-dust-server-29949745-56" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-56","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-56";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Lester John Lloyd, </li><li><a href="http://www.linkedin.com/pub/eric-johansson/0/17a/136">Eric Johansson</a></li></ul></dd></dl></div></div><div id="patent-276" class="editable-item section-item"><div id="patent-276-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D60%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=7QEy&trk=prof-patent-title-link" name="patent-site" target="_blank">Method of administration of insulin<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,672,581 </h5></hgroup><span class="patents-date">Issued&nbsp;September 30, 1997</span><p class="description summary-field-show-more">A method for treating a patient suffering from diabetes mellitus by delivering aerosolized insulin to the patient and a programmed, portable, hand-held device used in such treatment methodology is disclosed. Two basic types of drug delivery devices are disclosed for use in connection with the present invention. In accordance with the first type of device the insulin is contained within a low boiling point propellant which is held within a canister under pressure. In accordance with the second type of device the insulin is present within a container in solution and the solution is moved through a porous membrane to create an aerosolized formulation which is inhaled by the patient. In accordance with both devices a measured amount of insulin containing formulation is automatically released into the inspiratory flow path of a patient in response to information obtained from determining the inspiratory flow rate and inspiratory volume of a patient. The determination of values and release of drugs are carried out in real time. Reproducibly dosing of insulin to the patient is obtained by repeatedly providing for automatic release of insulin formulation at the same inspiratory flow rate and inspiratory volume. To maximize the efficiency of the delivery of the insulin formulation the formulation is released at an inspiratory flow rate in the range of from about 0.1 to about 2.0 liters/second and a measured inspiratory volume in the range of about 0.1 to about 0.8 liters.</p><script id="control-dust-server-29949745-57" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-57","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-57";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Lester John Lloyd</li></ul></dd></dl></div></div><div id="patent-279" class="editable-item section-item"><div id="patent-279-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D61%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=qPBi&trk=prof-patent-title-link" name="patent-site" target="_blank">Systems for the intrapulmonary delivery of aerosolized aqueous formulations<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,660,166 </h5></hgroup><span class="patents-date">Issued&nbsp;August 26, 1997</span><p class="description summary-field-show-more">A disposable package, tape, and cassette are provided which makes it possible to hold and disperse therefrom liquid, flowable formulations including aqueous formulations (solutions or dispersions with particles less than 0.25 microns in diameter) of a pharmaceutically active drug. In one embodiment formulation is packaged in individual dosage unit containers which containers are preferably interconnected. The package is designed to be integrated into a cassette which can be loaded into a dispersing device capable of individually opening dosage unit containers and aerosolizing the contents through a porous membrane, into a mouth piece on the cassette, for delivery to a patient. In addition to and alongside of each porous membrane, the package may include one or more openings through which air is forced in order to aid in avoiding the accumulation of aerosolized particles. The package may be configured so that the formulation is held in a container not positioned directly vertical to and below the porous membrane, thus making it necessary to channel formulation horizontally to the porous membrane and making it possible to include a vibrating mechanism directly below a chamber covered by the porous membrane. Release of aerosolized drug is breath actuated based on simultaneous measurements of inspiratory flow and volume so as to provide for repeatable dosing of drug to the patient.</p><script id="control-dust-server-29949745-58" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-58","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-58";}</script><dl class="associated-list education-associated associated-condensed"><dt>Inventors:</dt><dd class="associated-endorsements"><ul><li>Lester John Lloyd, </li><li>Peter Lloyd, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Jeffrey Schuster</li></ul></dd></dl></div></div><div id="patent-284" class="editable-item section-item"><div id="patent-284-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D62%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=LK9H&trk=prof-patent-title-link" name="patent-site" target="_blank">Delivery of aerosol medications for inspiration<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,655,516 </h5></hgroup><span class="patents-date">Issued&nbsp;August 12, 1997</span><p class="description summary-field-show-more">Apparatus and methods for delivering an amount of aerosolized medicine for inspiration by a patient in response to the occurrence of appropriate delivery point or points in the patient&#39;s detected breath flow. The aerosol medication may be administered as one or more pulses having a pulse width, shape, and frequency that will maximize the respirable fraction of the aerosolized compound being administered. The delivery point or points may be predetermined or determined from a prior inspiratory flow for depositing the selected medication at one or more desired locations in the patient&#39;s airway. Determined delivery points are recursively lowered for each inspiratory flow that does not satisfy one of the predetermined and previously lowered threshold. Changes in the patient&#39;s breath flow patterns during the course of an aerosolized medication inspiration therapy program may be detected and used to adjust the controlled amount of medication to be delivered in a given administration and/or to inform the patient of the patient&#39;s condition or change in condition. The device also may contain a library of administration protocols or operating parameters for different medications and a means for identifying from the canister the medicinal contents of the canister for customizing operation of the apparatus.</p><script id="control-dust-server-29949745-59" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-59","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-59";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li>David Goodman, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a></li></ul></dd></dl></div></div><div id="patent-287" class="editable-item section-item"><div id="patent-287-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D64%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=r8E6&trk=prof-patent-title-link" name="patent-site" target="_blank">Method and apparatus for releasing a controlled amount of aerosol medication over a selectable time interval<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,622,162 </h5></hgroup><span class="patents-date">Issued&nbsp;April 22, 1997</span><p class="description summary-field-show-more">A portable, battery powered, hand-held system for releasing a controlled dose of aerosol medication for inhalation by a patient including a durable body and a medication cassette inserted in the durable body. The cassette includes a housing for containing a canister of medication, bears an identification code, and permits the canister to be manually depressed to release a dose, e.g., a metered dose, when out of the durable body. The durable body includes an actuator mechanism for engaging an inserted cassette and its canister, and an actuator release mechanism for controlling the actuator mechanism to depress the canister for a selected period of time to release the desired dose of medication and then the release the canister. The actuator mechanism, includes a compression spring for depressing the canister and a torsion spring for reloading the compression spring. The torsion spring is reloaded by rotating the cassette from an open position for delivering aerosol to a closed position. The actuator release mechanism includes a motor and trigger pin assembly that controls the release of the compression spring and the torsion spring, and, hence, the time that the canister is depressed. The motor operates in response to sensed flow satisfying a selected delivery threshold. The durable body includes a flow sensor having an asymmetrical orifice that is calibrated, independent of the cassette, to convert the sensed pressure due to flow into a flow rate. The orifice is separately calibrated for an inhalation flow rate range and an exhalation flow rate range over a selected number of known flow rates. The sensed pressure value is corrected for transducer offset drift and converted to a flow rate using the calibration data and piecewise linear interpolation.</p><script id="control-dust-server-29949745-60" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-60","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-60";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/eric-johansson/0/17a/136">Eric Johansson</a>, </li><li>Ritson karl, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a></li></ul></dd></dl></div></div><div id="patent-291" class="editable-item section-item"><div id="patent-291-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D65%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=0M_w&trk=prof-patent-title-link" name="patent-site" target="_blank">Method for releasing controlled amount of aerosol medication<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,608,647 </h5></hgroup><span class="patents-date">Issued&nbsp;March 4, 1997</span><p class="description summary-field-show-more">A method for releasing a controlled amount of aerosol medication is disclosed. The method of the invention is preferably used in connection with a portable, battery-powered, hand-held system for releasing a controlled dose of aerosol medication for inhalation by a patient. The inhalation breath flow of the user of the apparatus is monitored and the inhalation flow rate is measured, and inhalation volume is determined as a function of the measured flow rate. The measured flow rate is compared to predetermined minimum and maximum flow rate thresholds, and the determined flow volume is compared to predetermined minimum and maximum flow volume thresholds. When both the measured flow rate and the measured flow volume are between their respective the minimum and maximum thresholds, a signal is provided to release a controlled amount of aerosol.</p><script id="control-dust-server-29949745-61" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-61","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-61";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/eric-johansson/0/17a/136">Eric Johansson</a></li></ul></dd></dl></div></div><div id="patent-294" class="editable-item section-item"><div id="patent-294-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D67%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=FHS-&trk=prof-patent-title-link" name="patent-site" target="_blank">Intrapulmonary delivery of peptide drugs<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,558,085 </h5></hgroup><span class="patents-date">Issued&nbsp;September 24, 1996</span><p class="description summary-field-show-more">A method of treating human patients is provided by the intrapulmonary delivery of a pharmaceutically active peptide formulation. The formulation is automatically released in an aerosolized form from a hand-held, self-contained, portable device comprised of a means for automatically releasing a measured amount of drug into the inspiratory flow path of a patient in response to information obtained from a means for measuring the inspiratory flow rate and determining the inspiratory volume of a patient. Reproducible dosing is obtained by providing for automatic release at the same inspiratory flow rate and inspiratory volume each time drug is released. The device includes a timer to enable a patient to take a drug at the same time each day. Further, overadministration of hormone formulations is avoided by providing a pre-programmed microprocessor designed to avoid overdosing.</p><script id="control-dust-server-29949745-62" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-62","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-62";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Lester John Lloyd</li></ul></dd></dl></div></div><div id="patent-297" class="editable-item section-item"><div id="patent-297-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D68%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=juhD&trk=prof-patent-title-link" name="patent-site" target="_blank">Systems for the intrapulmonary delivery of aerosolized aqueous formulations<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,544,646 </h5></hgroup><span class="patents-date">Issued&nbsp;August 13, 1996</span><p class="description summary-field-show-more">A disposable package, tape, and cassette are provided which makes it possible to hold and disperse therefrom liquid, flowable formulations including aqueous formulations (solutions or dispersions with particles less than 0.25 microns in diameter) of a pharmaceutically active drug. In one embodiment formulation is packaged in individual dosage unit containers which containers are preferably interconnected. The package is designed to be integrated into a cassette which can be loaded into a dispersing device capable of individually opening dosage unit containers and aerosolizing the contents through a porous membrane, into a mouth piece on the cassette, for delivery to a patient. In addition to and alongside of each porous membrane, the package may include one or more openings through which air is forced in order to aid in avoiding the accumulation of aerosolized particles. The package may be configured so that the formulation is held in a container not positioned directly vertical to and below the porous membrane, thus making it necessary to channel formulation horizontally to the porous membrane and making it possible to include a vibrating mechanism directly below a chamber covered by the porous membrane. Release of aerosolized drug is breath actuated based on simultaneous measurements of inspiratory flow and volume so as to provide for repeatable dosing of drug to the patient.</p><script id="control-dust-server-29949745-63" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-63","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-63";}</script><dl class="associated-list education-associated associated-condensed"><dt>Inventors:</dt><dd class="associated-endorsements"><ul><li>Peter Lloyd, </li><li>Lester John Lloyd, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Jeffrey Schuster</li></ul></dd></dl></div></div><div id="patent-302" class="editable-item section-item"><div id="patent-302-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D69%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=zH5F&trk=prof-patent-title-link" name="patent-site" target="_blank">Delivery of aeerosol medications for inspiration<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,542,410 </h5></hgroup><span class="patents-date">Issued&nbsp;August 6, 1996</span><p class="description summary-field-show-more">Apparatus and methods for delivering an amount of aerosolized medicine for inspiration by a patient in response to the occurrence of appropriate delivery point or points in the patient&#39;s detected breath flow. The aerosol medication may be administered as one or more pulses having a pulse width, shape, and frequency that will maximize the respirable fraction of the aerosolized compound being administered. The delivery point or points may be predetermined or determined from a prior inspiratory flow for depositing the selected medication at one or more desired locations in the patient&#39;s airway. Determined delivery points are recursively lowered for each inspiratory flow that does not satisfy one of the predetermined and previously lowered threshold. Changes in the patient&#39;s breath flow patterns during the course of an aerosolized medication inspiration therapy program may be detected and used to adjust the controlled amount of medication to be delivered in a given administration and/or to inform the patient of the patient&#39;s condition or change in condition. The device also may contain a library of administration protocols or operating parameters for different medications and a means for identifying from the canister the medicinal contents of the canister for customizing operation of the apparatus.</p><script id="control-dust-server-29949745-64" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-64","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-64";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li>David Goodman, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a></li></ul></dd></dl></div></div><div id="patent-305" class="editable-item section-item"><div id="patent-305-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D70%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=ReY_&trk=prof-patent-title-link" name="patent-site" target="_blank">Dynamic particle size control for aerosolized drug delivery<span class="external-link-indicator">(Link)</span></a></h4><h5>United States June 4, 1996 </h5></hgroup><span class="patents-date">Issued&nbsp;June 4, 1996</span><p class="description summary-field-show-more">A device is provided which creates aerosolized particles by forcing a formulation of drug in a carrier through a nozzle (which nozzle may be in the form of a porous membrane) into a channel to a patient for inhalation. While in the channel energy is added to the particles in an amount sufficient to evaporate carrier and thereby reduce particle size. The amount of energy added can be adjusted depending on factors such as the particle size, the amount of the carrier to be evaporated, the water vapor content of the surrounding air and the composition of the carrier. Energy may be added in an amount sufficient to evaporate all carrier and thereby provide particles of dry powdered drug to patient which particles are uniform in size regardless of the surrounding humidity and smaller due to the evaporation of the carrier. Air drawn into the device by the patient may be drawn through a desiccator containing a desiccant which removes moisture from the air thereby improving evaporation efficiency when the carrier is water. Alternatively, water vapor may be introduced to the channel to saturate inhaled air thereby preventing evaporation of carrier and maintaining uniform particle size.</p><script id="control-dust-server-29949745-65" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-65","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-65";}</script><dl class="associated-list education-associated associated-condensed"><dt>Inventors:</dt><dd class="associated-endorsements"><ul><li>Lester John Lloyd, </li><li>Peter Lloyd, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Jeffrey Schuster</li></ul></dd></dl></div></div><div id="patent-310" class="editable-item section-item"><div id="patent-310-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D71%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=yqPo&trk=prof-patent-title-link" name="patent-site" target="_blank">Automatic aerosol medication delivery system and methods<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,522,378 </h5></hgroup><span class="patents-date">Issued&nbsp;June 4, 1996</span><p class="description summary-field-show-more">A portable, battery powered, hand-held system for releasing a controlled dose of aerosol medication for inhalation by a patient including a durable body and a medication cassette inserted in the durable body. The cassette includes a housing for containing a canister of medication, bears an identification code, and permits the canister to be manually depressed to release a dose, e.g., a metered dose, when out of the durable body. The durable body includes an actuator mechanism for engaging an inserted cassette and its canister, and an actuator release mechanism for controlling the actuator mechanism to depress the canister for a selected period of time to release the desired dose of medication and then the release the canister. The actuator mechanism, includes a compression spring for depressing the canister and a torsion spring for reloading the compression spring. The torsion spring is reloaded by rotating the cassette from an open position for delivering aerosol to a closed position. The actuator release mechanism includes a motor and trigger pin assembly that controls the release of the compression spring and the torsion spring, and, hence, the time that the canister is depressed. The motor operates in response to sensed flow satisfying a selected delivery threshold. The durable body includes a flow sensor having an asymmetrical orifice that is calibrated, independent of the cassette, to convert the sensed pressure due to flow into a flow rate. The orifice is separately calibrated for an inhalation flow rate range and an exhalation flow rate range over a selected number of known flow rates. The sensed pressure value is corrected for transducer offset drift and converted to a flow rate using the calibration data and piecewise linear interpolation.</p><script id="control-dust-server-29949745-66" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-66","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-66";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li>Karl Ritson, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a></li></ul></dd></dl></div></div><div id="patent-313" class="editable-item section-item"><div id="patent-313-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D72%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=NAmW&trk=prof-patent-title-link" name="patent-site" target="_blank">Medication cassette for an automatic aerosol medication delivery system<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,520,166 </h5></hgroup><span class="patents-date">Issued&nbsp;May 28, 1996</span><p class="description summary-field-show-more">A portable, battery powered, hand-held system for releasing a controlled dose of aerosol medication for inhalation by a patient including a durable body and a medication cassette inserted in the durable body. The cassette includes a housing for containing a canister of medication, bears an identification code, and permits the canister to be manually depressed to release a dose, e.g., a metered dose, when out of the durable body. The durable body includes an actuator mechanism for engaging an inserted cassette and its canister, and an actuator release mechanism for controlling the actuator mechanism to depress the canister for a selected period of time to release the desired dose of medication and then the release the canister. The actuator mechanism, includes a compression spring for depressing the canister and a torsion spring for reloading the compression spring. The torsion spring is reloaded by rotating the cassette from an open position for delivering aerosol to a closed position. The actuator release mechanism includes a motor and trigger pin assembly that controls the release of the compression spring and the torsion spring, and, hence, the time that the canister is depressed. The motor operates in response to sensed flow satisfying a selected delivery threshold. The durable body includes a flow sensor having an asymmetrical orifice that is calibrated, independent of the cassette, to convert the sensed pressure due to flow into a flow rate. The orifice is separately calibrated for an inhalation flow rate range and an exhalation flow rate range over a selected number of known flow rates. The sensed pressure value is corrected for transducer offset drift and converted to a flow rate using the calibration data and piecewise linear interpolation.</p><script id="control-dust-server-29949745-67" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-67","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-67";}</script></div></div><div id="patent-315" class="editable-item section-item"><div id="patent-315-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D73%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=ta_C&trk=prof-patent-title-link" name="patent-site" target="_blank">Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,509,404 </h5></hgroup><span class="patents-date">Issued&nbsp;April 23, 1996</span><p class="description summary-field-show-more">A method of drug delivery is disclosed wherein a patient&#39;s inspiratory flow rate and inspiratory volume are simultaneously measured using a portable, hand-held, device which may be electronic and battery-powered or mechanical. Information obtained from the measurement is used to release, into a patient&#39;s inspiratory flow path, particles of a pharmaceutically active drug. The released particles have a particle size in the range of from about 0.5 to 12 microns. The drug is released when the patient&#39;s measured inspiratory flow rate is in the range of from about 0.10 to about 2.0 liters/second and the patient&#39;s inspiratory volume is in the range of from about 0.15 to about 0.8 liters. By measuring inspiratory flow and volume and releasing within the specific parameters with respect to both flow and volume, it is possible to obtain a high degree of repeatability with respect to dosing of a patient and further to deliver a relatively high percentage of the released drug to the patient&#39;s circulatory system.</p><script id="control-dust-server-29949745-68" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-68","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-68";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li>Lester John Lloyd, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a></li></ul></dd></dl></div></div><div id="patent-318" class="editable-item section-item"><div id="patent-318-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D74%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=86Mf&trk=prof-patent-title-link" name="patent-site" target="_blank">Lockout device for controlled release of drug from patient-activateddispenser<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,507,277 </h5></hgroup><span class="patents-date">Issued&nbsp;April 16, 1996</span><p class="description summary-field-show-more">A method of controlling access to a drug in an aerosol drug delivery device by an electronic lock and key means is disclosed. Access is limited to the intended user by providing the intended user with a uniquely coded, machine readable key means that matches the unique code of the lock means. Contacting matching lock and key means signals a controlling means to allow use of the device. Specifically, the method is applied to a method of pain control provided by the intrapulmonary delivery of a pharmaceutically active pain relief formulation. The formulation is automatically released from a hand-held, self-contained, portable device comprised of a means for automatically releasing a measured amount of drug into the inspiratory flow path of a patient in response to information obtained from a means for measuring and separately determining inspiratory flow rate and inspiratory volume of a patient. Reproducible dosing is obtained by providing for automatic release in response to a separately measured inspiratory rate and inspiratory volume. To obtain repeatability in dosing the narcotic formulation is repeatedly released at the same measured (1) inspiratory flow rate and (2) inspiratory volume. To maximize the efficiency of the delivery the narcotic formulation is released at (1) a measured inspiratory flow rate in the range of from about 0.10 to about 2.0 liters/second and (2) a measured inspiratory volume in the range of about 0.15 to about 0.8 liters. Abuse of narcotic formulations is avoided by providing a tamper-resistant device which includes a variety of security features including an electronic lock and key means and a pre-programmed microprocessor designed to avoid overdosing.</p><script id="control-dust-server-29949745-69" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-69","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-69";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Lester John Lloyd, </li><li><a href="http://www.linkedin.com/pub/eric-johansson/0/17a/136">Eric Johansson</a></li></ul></dd></dl></div></div><div id="patent-322" class="editable-item section-item"><div id="patent-322-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D75%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=X82M&trk=prof-patent-title-link" name="patent-site" target="_blank">Medication cassette for an automatic aerosol medication delivery<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,497,764 </h5></hgroup><span class="patents-date">Issued&nbsp;March 12, 1996</span><p class="description summary-field-show-more">A portable, battery powered, hand-held system for releasing a controlled dose of aerosol medication for inhalation by a patient including a durable body and a medication cassette inserted in the durable body. The cassette includes a housing for containing a canister of medication, bears an identification code, and permits the canister to be manually depressed to release a dose, e.g., a metered dose, when out of the durable body. The durable body includes an actuator mechanism for engaging an inserted cassette and its canister, and an actuator release mechanism for controlling the actuator mechanism to depress the canister for a selected period of time to release the desired dose of medication and then the release the canister. The actuator mechanism, includes a compression spring for depressing the canister and a torsion spring for reloading the compression spring. The torsion spring is reloaded by rotating the cassette from an open position for delivering aerosol to a closed position. The actuator release mechanism includes a motor and trigger pin assembly that controls the release of the compression spring and the torsion spring, and, hence, the time that the canister is depressed. The motor operates in response to sensed flow satisfying a selected delivery threshold. The durable body includes a flow sensor having an asymmetrical orifice that is calibrated, independent of the cassette, to convert the sensed pressure due to flow into a flow rate. The orifice is separately calibrated for an inhalation flow rate range and an exhalation flow rate range over a selected number of known flow rates. The sensed pressure value is corrected for transducer offset drift and converted to a flow rate using the calibration data and piecewise linear interpolation.</p><script id="control-dust-server-29949745-70" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-70","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-70";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>Karl Ritson</li></ul></dd></dl></div></div><div id="patent-325" class="editable-item section-item"><div id="patent-325-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D76%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=nCI0&trk=prof-patent-title-link" name="patent-site" target="_blank">Disposable package for intrapulmonary delivery of aerosolized formulations<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,497,763 </h5></hgroup><span class="patents-date">Issued&nbsp;March 12, 1996</span><p class="description summary-field-show-more">A disposable package is provided which makes it possible to hold and disperse therefrom liquid, flowable formulations including aqueous formulations (solutions or dispersions with particles less than 0.25 microns in diameter) of a pharmaceutically active drug. The formulation is packaged in individual dosage unit containers which containers are preferably interconnected. The package is designed to be integrated into a cassette which can be loaded into a dispersing device capable of individually opening dosage unit containers and aerosolizing the contents through a porous membrane, into a mouth piece on the cassette, for delivery to a patient. In addition to and alongside of each porous membrane, the package preferably includes one or more openings through which air is forced in order to aid in avoiding the accumulation of aerosolized particles. The package is configured so that the formulation is held in a container not positioned directly vertical to and below the porous membrane, thus making it necessary to channel formulation horizontally to the porous membrane and making it possible to include a vibrating mechanism directly below a chamber covered by the porous membrane. Release of aerosolized drug is breath actuated in a manner so as to provide for repeatable dosing of drug to the patient.</p><script id="control-dust-server-29949745-71" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-71","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-71";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li>Lester John Lloyd, </li><li>Peter Lloyd, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a></li></ul></dd></dl></div></div><div id="patent-329" class="editable-item section-item"><div id="patent-329-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D77%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=2mZU&trk=prof-patent-title-link" name="patent-site" target="_blank">Method and apparatus for sensing flow in two directions and automatic calibration thereof<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,469,750 </h5></hgroup><span class="patents-date">Issued&nbsp;November 28, 1995</span><p class="description summary-field-show-more">A method of calibrating the output of a transducer in a flow path through which a medication is delivered from a hand-held metered dose inhaler is disclosed. The transducer senses flow rates of human breath during inhalation and exhalation through a portion of a flow path in the inhaler. The flow rates have two non-linear flow characteristics in opposite directions. The flow path portion provides flow rate measurements representative of flow paths of the entire system. The method makes it possible to precisely calibrate so that precise doses of medication can be repeatedly delivered to a patient by inhalation.</p><script id="control-dust-server-29949745-72" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-72","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-72";}</script><dl class="associated-list education-associated associated-condensed"><dt>Inventors:</dt><dd class="associated-endorsements"><ul><li>Lester John Lloyd, </li><li>Karl Ritson, </li><li><a href="http://www.linkedin.com/pub/eric-johansson/0/17a/136">Eric Johansson</a>, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a></li></ul></dd></dl></div></div><div id="patent-334" class="editable-item section-item"><div id="patent-334-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D78%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=74KL&trk=prof-patent-title-link" name="patent-site" target="_blank">Method for correcting the drift offset of a transducer<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,450,336 </h5></hgroup><span class="patents-date">Issued&nbsp;September 12, 1995</span><p class="description summary-field-show-more">A method for correcting the drift offset of a transducer is disclosed which method is used in connection with a portable, battery-powered, hand-held system for releasing a controlled dose of aerosol medication for inhalation by a patient. The device includes a durable body and a medication cassette inserted in the durable body. The body includes a flow sensor having an asymmetrical orifice that is calibrated, independent of the cassette, to convert the sensed pressure due to flow into a flow rate. The orifice is separately calibrated for an inhalation flow rate range and an exhalation flow rate range over a selected number of known flow rates. The sensed pressure value is corrected for transducer offset drift and converted to a flow rate using the calibration data and piecewise linear interpolation.</p><script id="control-dust-server-29949745-73" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-73","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-73";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/eric-johansson/0/17a/136">Eric Johansson</a></li></ul></dd></dl></div></div><div id="patent-337" class="editable-item section-item"><div id="patent-337-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D79%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=AvDr&trk=prof-patent-title-link" name="patent-site" target="_blank">Intrapulmonary delivery of hormones<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,419,315 </h5></hgroup><span class="patents-date">Issued&nbsp;May 30, 1995</span><p class="description summary-field-show-more">A method of treating human patients is provided by the intrapulmonary delivery of a pharmaceutically active hormone formulation. The formulation is automatically released from a hand-held, self-contained, portable device comprised of a means for automatically releasing a measured amount of drug into the inspiratory flow path of a patient in response to information obtained from a means for analyzing the inspiratory flow of a patient and after the patient is sent an audible or visual signal. Reproducible dosing is obtained by providing for automatic release in response to a measured inhalation profile. The overadministration of hormone formulations is avoided by providing a pre-programmed microprocessor designed to avoid overdosing.</p><script id="control-dust-server-29949745-74" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-74","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-74";}</script></div></div><div id="patent-339" class="editable-item section-item"><div id="patent-339-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D80%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=V7SQ&trk=prof-patent-title-link" name="patent-site" target="_blank">Delivery of aerosol medications for inspiration<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,404,871 </h5></hgroup><span class="patents-date">Issued&nbsp;April 11, 1995</span><p class="description summary-field-show-more">Apparatus and methods for delivering an amount of aerosolized medicine for inspiration by a patient in response to the occurrence of appropriate delivery point or points in the patient&#39;s detected breath flow. The aerosol medication may be administered as one or more pulses having a pulse width, shape, and frequency that will maximize the respirable fraction of the aerosolized compound being administered. The delivery point or points may be predetermined or determined from a prior inspiratory flow for depositing the selected medication at one or more desired locations in the patient&#39;s airway. Determined delivery points are recursively lowered for each inspiratory flow that does not satisfy one of the predetermined and previously lowered threshold. Changes in the patient&#39;s breath flow patterns during the course of an aerosolized medication inspiration therapy program may be detected and used to adjust the controlled amount of medication to be delivered in a given administration and/or to inform the patient of the patient&#39;s condition or change in condition. The device also may contain a library of administration protocols or operating parameters for different medications and a means for identifying from the canister the medicinal contents of the canister for customizing operation of the apparatus.</p><script id="control-dust-server-29949745-75" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-75","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-75";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li>David Goodman, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a></li></ul></dd></dl></div></div><div id="patent-342" class="editable-item section-item"><div id="patent-342-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D81%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=tGUe&trk=prof-patent-title-link" name="patent-site" target="_blank">Automatic aerosol medication delivery system and methods<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,394,866 </h5></hgroup><span class="patents-date">Issued&nbsp;March 7, 1995</span><p class="description summary-field-show-more">A portable, battery powered, hand-held system for releasing a controlled dose of aerosol medication for inhalation by a patient including a durable body and a medication cassette inserted in the durable body. The cassette includes a housing for containing a canister of medication, bears an identification code, and permits the canister to be manually depressed to release a dose, e.g., a metered dose, when out of the durable body. The durable body includes an actuator mechanism for engaging an inserted cassette and its canister, and an actuator release mechanism for controlling the actuator mechanism to depress the canister for a selected period of time to release the desired dose of medication and then the release the canister. The actuator mechanism, includes a compression spring for depressing the canister and a torsion spring for reloading the compression spring. The torsion spring is reloaded by rotating the cassette from an open position for delivering aerosol to a closed position. The actuator release mechanism includes a motor and trigger pin assembly that controls the release of the compression spring and the torsion spring, and, hence, the time that the canister is depressed.</p><script id="control-dust-server-29949745-76" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-76","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-76";}</script></div></div><div id="patent-344" class="editable-item section-item"><div id="patent-344-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D82%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=oVSf&trk=prof-patent-title-link" name="patent-site" target="_blank">Method and apparatus for releasing a controlled amount of aerosol medication over a selectable time interval<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,392,768 </h5></hgroup><span class="patents-date">Issued&nbsp;February 28, 1995</span><p class="description summary-field-show-more">A portable, battery powered, hand-held system for releasing a controlled dose of aerosol medication for inhalation by a patient including a durable body and a medication cassette inserted in the durable body. The cassette includes a housing for containing a canister of medication, bears an identification code, and permits the canister to be manually depressed to release a dose, e.g., a metered dose, when out of the durable body. The durable body includes an actuator mechanism for engaging an inserted cassette and its canister, and an actuator release mechanism for controlling the actuator mechanism to depress the canister for a selected period of time to release the desired dose of medication and then the release the canister. The actuator mechanism, includes a compression spring for depressing the canister and a torsion spring for reloading the compression spring. The torsion spring is reloaded by rotating the cassette from an open position for delivering aerosol to a closed position. The actuator release mechanism includes a motor and trigger pin assembly that controls the release of the compression spring and the torsion spring, and, hence, the time that the canister is depressed. The motor operates in response to sensed flow satisfying a selected delivery threshold. The durable body includes a flow sensor having an asymmetrical orifice that is calibrated, independent of the cassette, to convert the sensed pressure due to flow into a flow rate. The orifice is separately calibrated for an inhalation flow rate range and an exhalation flow rate range over a selected number of known flow rates. The sensed pressure value is corrected for transducer offset drift and converted to a flow rate using the calibration data and piecewise linear interpolation.</p><script id="control-dust-server-29949745-77" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-77","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-77";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Inventors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/eric-johansson/0/17a/136">Eric Johansson</a>, </li><li>Karl Ritson, </li><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a></li></ul></dd></dl></div></div><div id="patent-348" class="editable-item section-item"><div id="patent-348-view"><hgroup><h4><a href="/redir/redirect?url=http%3A%2F%2Fpatft%2Euspto%2Egov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv%2Ehtm%26r%3D83%26f%3DG%26l%3D50%26d%3DPTXT%26s1%3Drubsamen%2EINNM%2E%26p%3D2%26OS%3Din%2Frubsamen%26RS%3DIN%2Frubsamen&amp;urlhash=KV8A&trk=prof-patent-title-link" name="patent-site" target="_blank">Method of administration of insulin<span class="external-link-indicator">(Link)</span></a></h4><h5>United States 5,364,838 </h5></hgroup><span class="patents-date">Issued&nbsp;November 15, 1994</span><p class="description summary-field-show-more">A method for treating a patient suffering from diabetes mellitus and a programmed, portable, hand-held device and formulations used in such treatment methodology is disclosed. The programmed device is loaded with a container which includes a formulation comprised of insulin dispersed in a suitable propellant such as a low boiling point propellant. The container may be completely sealed and may be punctured on insertion in the device but preferably includes a single valve which can be opened to release insulin forced from the container by the propellant. A valve for releasing formulation is controlled by an electronic means for opening the valve in response to a measured threshold of airflow which airflow is measured by an airflow detection means positioned between the valve and a mouthpiece. Insulin is administered when the patient inspiratory flow exceeds a preset threshold. The airflow is measured and when a threshold amount of airflow is achieved, the valve opening means is actuated and a controlled amount of insulin is released from the container. The device includes a microprocessor connected to the means for measuring airflow and the means for opening the valve. The microprocessor is programmed to control the amount of insulin released, based on the particular needs of the patient. The device is electronically connectable to a device which measures serum glucose level and can adjust insulin release amounts based of measured glucose levels.</p><script id="control-dust-server-29949745-78" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-78","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-78";}</script></div></div><script>if(LI.Dialog){LI.Dialog().submitEvent.subscribe(function(type,args){var patentID;if(args[1]=='removePatentDialog'&&WebTracking&&WebTracking.trackUserAction){if(args[2]&&args[2].patentID){patentID=args[2].patentID;}WebTracking.trackUserAction('nprofile-edit-patent-remove-submit',{patentID:patentID});}});}</script></div></div><div id="background-projects-container" class="background-section" data-li-template="projects_section"><div id="background-projects" class="background-projects "><h3>Projects</h3><div id="project-54" class="editable-item section-item"><div id="project-54-view"><hgroup><h4 class="summary fn org"><a href="/redir/redirect?url=http%3A%2F%2Fwww%2Eimmunityproject%2Eorg&amp;urlhash=AJyP&trk=prof-project-name-link" name="project-site" target="_blank">Immunity Project<span class="external-link-indicator">(Link)</span></a></h4></hgroup><span class="projects-date"><time>September 2013</time></span><p class="description summary-field-show-more">We are a team of scientists and entrepreneurs based in the San Francisco Bay Area and we have developed a novel, phase 1 ready HIV vaccine.</p><script id="control-dust-server-29949745-79" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-79","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-79";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Team members:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li><a href="http://www.linkedin.com/pub/nora-hanna/5/485/1a3">Nora Hanna</a>, </li><li><a href="http://www.linkedin.com/pub/naveen-jain/0/599/ba1">Naveen Jain</a></li></ul></dd></dl></div></div><script>if(LI.Dialog){LI.Dialog().submitEvent.subscribe(function(type,args){var projectID;if(args[1]=='removeProjectDialog'&&WebTracking&&WebTracking.trackUserAction){if(args[2]&&args[2].projectID){projectID=args[2].projectID;}WebTracking.trackUserAction('nprofile-edit-project-remove-submit',{projectID:projectID});}});}</script></div></div><div id="background-volunteering-container" class="background-section" data-li-template="volunteering_section"><div id="background-volunteering" class="background-volunteering "><h3>Volunteer Experience &amp; Causes</h3><div id="volunteering-53" class="editable-item section-item"><div id="volunteering-53-view"><div class="experience"><hgroup><h5 class="volunteering-logo"></h5><h4>Staff Anesthesiologist</h4><h5>MPO Nicaragua</h5></hgroup><span class="volunteering-date-cause"><time>December 2007</time><span class="locality">Health</span></span><p class="description summary-field-show-more">Delivering medical care to the people of Nicaragua and providing support to the NGO MPO which brings advanced surgical services to Leon University Hospital.</p><script id="control-dust-server-29949745-80" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-80","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-80";}</script></div></div></div><script>if(LI.Dialog){LI.Dialog().submitEvent.subscribe(function(type,args){var volexpID;if(args[1]=='removeVolunteeringExperienceDialog'&&WebTracking&&WebTracking.trackUserAction){if(args[2]&&args[2].volexpID){volexpID=args[2].volexpID;}WebTracking.trackUserAction('profile-edit-vol_exp-remove-submit',{volexpID:volexpID});}});}</script><div id="volunteering-opportunities" class="editable-item no-content"><div id="volunteering-opportunities-view" class="volunteer-section no-content"><h4 class="volunteering-interests-special-header">Opportunities Reid is looking for:</h4></div></div><div id="volunteering-interests" class="editable-item section-item first"><div id="volunteering-causes-view" class="volunteer-section no-content"><div class="interests"><h4 class="volunteering-interests-special-header">Causes Reid cares about:</h4></div></div><div id="volunteering-organizations-view" class="volunteer-section no-causes"><div class="non-profits "><h4>Organizations Reid supports:</h4><ul class="volunteering-listing"><li>Until There&#39;s A Cure Foundation</li></ul></div></div></div></div></div><div id="background-publications-container" class="background-section" data-li-template="publications_section"><div id="background-publications" class="background-publications "><h3>Publications</h3><div id="publication-23" class="editable-item section-item"><div id="publication-23-view"><hgroup><h4><a href="/redir/redirect?url=https%3A%2F%2Fna14%2Esalesforce%2Ecom%2Fsfc%2Fp%2Fd0000000dZi4PrjoQbg3uF2mypiI9xGsqZ7qAQk%3D&amp;urlhash=NN3f&trk=prof-publication-title-link" name="publication-site" target="_blank">US Patent Application Publication US201103002261<span class="external-link-indicator">(Link)</span></a></h4><h5>USPTO</h5></hgroup><span class="publication-date">December 2011</span><p class="description summary-field-show-more">Covers FlowPharma Technology for vaccine delivery</p><script id="control-dust-server-29949745-81" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-81","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-81";}</script><dl class="associated-list education-associated associated-condensed"><dt class="no-interaction">Authors:</dt><dd class="associated-endorsements"><ul><li><a href="http://www.linkedin.com/pub/reid-rubsamen-m-d/7/410/0">Reid Rubsamen, M.D.</a>, </li><li>David Heckerman, M.D., Ph.D.</li></ul></dd></dl></div></div><div id="publication-20" class="editable-item section-item"><div id="publication-20-view"><hgroup><h4><a href="/redir/redirect?url=https%3A%2F%2Fna14%2Esalesforce%2Ecom%2Fsfc%2Fp%2Fd0000000dZi4u9QzMO33CMjOqSSh_5HiaAnRrcM%3D&amp;urlhash=1Vdm&trk=prof-publication-title-link" name="publication-site" target="_blank">US Patent 8,138,157<span class="external-link-indicator">(Link)</span></a></h4><h5>USPTO</h5></hgroup><span class="publication-date">March 2012</span><p class="description summary-field-show-more">Covers FlowPharma technology for surgical site infection prevention</p><script id="control-dust-server-29949745-82" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-82","ShowMore",{charCount:400,showMoreText:"more",showLessText:"less"})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-82";}</script></div></div><script>if(LI.Dialog){LI.Dialog().submitEvent.subscribe(function(type,args){var publicationID;if(args[1]=='removePublicationDialog'&&WebTracking&&WebTracking.trackUserAction){if(args[2]&&args[2].publicationID){publicationID=args[2].publicationID;}WebTracking.trackUserAction('nprofile-edit-publications-remove-submit',{publicationID:publicationID});}});}</script></div></div><div id="background-skills-container" class="background-section" data-li-template="skills_section"><div id="background-skills" class="background-skills edit-default "><div class="hd"><h3>Skills</h3></div><div id="skills-error-alert"></div><div id="skills-item" class="editable-item"><div id="skills-item-view"><div id="profile-skills"><ul class="skills-section compact-view"><li class="endorse-item "><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Board Certified...</span></span></span></li><li class="endorse-item "><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Engineer</span></span></span></li><li class="endorse-item "><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Entrepreneur</span></span></span></li><li class="endorse-item "><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Clinical Research</span></span></span></li><li class="endorse-item "><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Medicine</span></span></span></li><li class="endorse-item "><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Clinical Trials</span></span></span></li><li class="endorse-item "><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Medical Devices</span></span></span></li><li class="endorse-item "><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Informatics</span></span></span></li><li class="endorse-item "><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Healthcare</span></span></span></li><li class="endorse-item "><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Board Certified</span></span></span></li><li class="endorse-item "><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Healthcare Management</span></span></span></li><li class="endorse-item "><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Hospitals</span></span></span></li><li class="endorse-item "><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Medical Education</span></span></span></li><li class="endorse-item "><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Surgery</span></span></span></li><li class="endorse-item "><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Biotechnology</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Healthcare Information...</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Lifesciences</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Pharmaceutical Industry</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Clinical Development</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Entrepreneurship</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">FDA</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Infectious Diseases</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Anesthesia</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Patient Safety</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">EMR</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Treatment</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Regulatory Affairs</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">EHR</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Cancer</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Healthcare Consulting</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Physicians</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Medical Device R&amp;D</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Technology Integration</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Patient Outcomes</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Medical Technology</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Managed Care</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Medical Imaging</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Radiology</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Hardware Diagnostics</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Healthcare Industry</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Public Health</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Health Information...</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Neuroscience</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Revenue Cycle</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">HIPAA</span></span></span></li><li class="endorse-item extra-skill"><span class="skill-pill"><span class="endorse-item-name "><span class="endorse-item-name-text">Critical Care</span></span></span></li><li class="endorse-item" id="see-more-less-skill"><span class="see-more-less skill-pill"><a href="javascript:void(0)"><span class="more-text">See 31+</span><span class="more-arrow">&nbsp;</span><span class="less-arrow">&nbsp;</span><span class="less-text">See less</span></a></span><script id="control-dust-server-29949745-83" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-83","ToggleClass",{classname:'view-all-skills',on:'#profile-skills'})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-83";}</script></li></ul></div><script id="control-dust-server-29949745-84" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-29949745-84","ProfileSectionSkills",{viewerId:'0',dialogConfig:{dustDataUrl:'\/profile\/endorser-info-dialog?csrfToken=ajax%3A8819885718929664622',width:600,name:'skills-endorsers-dialog',className:'skills-endorser-dialog dialog-v2',type:'task-modeless',disableFocusOnClose:true,content:{title:'Endorsers',dustTemplate:'tl/apps/profile/endorsements/endorser_Info_dialog'},dependencies:{jsFiles:'http://s.c.lnkd.licdn.com/scds/concat/common/js?h=p3w9atlr7l86s8yz6um7wlsp&fc=2'}},endorsementData:{recipientId:'21917952',recipientType:'member'},distance:-1,isSelf:false,maxEndorsementCount:99,endorseURL:'\/profile\/endorse?_ed=0_2KjZg6oXb2V2F89fO9b1Jr9vVefjgmMy5Eg5IR_1O8f&csrfToken=ajax%3A8819885718929664622&goback=%2Enppvan_reidrubsamenmd',unendorseURL:'\/profile\/unendorse?_ed=0_2KjZg6oXb2V2F89fO9b1Jr9vVefjgmMy5Eg5IR_1O8f&csrfToken=ajax%3A8819885718929664622&goback=%2Enppvan_reidrubsamenmd',i18nMaxEndorsements:'99+',i18nEndorseLimitExceeded:'That\'s all the endorsements you can send today. Send a personal message instead, or start again tomorrow.',i18nUnendorseLimitExceeded:'Sorry, something went wrong. Please try again later.'})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-29949745-84";}</script></div></div></div></div><div id="background-education-container" class="background-section" data-li-template="education_section"><div id="background-education" class="background-education edit-default "><h3>Education</h3><div id="education-33278945" class="editable-item section-item"><div id="education-33278945-view"><div class="education first"><a href='/edu/school?id=18494&amp;trk=ppro_sprof' title="More details for this school"><h5 class="education-logo"><img src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_60_60/p/3/005/028/07b/31e15c4.png" alt="Massachusetts Institute of Technology"/></h5></a><header><h4 class="summary fn org"><a href='/edu/school?id=18494&amp;trk=ppro_sprof' title="More details for this school">Massachusetts Institute of Technology</a></h4><h5><span class="degree">NONE, </span><span class="major"><a href="/edu/fos?id=100189&amp;trk=prof-edu-field_of_study" title="Explore this field of study">Computer Science</a></span></h5></header><span class="education-date"><time>1989</time><time> &#8211; 1991</time></span><p class="notes summary-field-show-more">Worked in the Laboratory of Computer Science with Dr. Peter Solovitz on advanced techniques for automatic interpretation of physiologic data. Designed and wrote the MGH Hemodynamic Waveform Database allowing easy access to archived, multi-channel, physiologic waveform data.</p></div></div></div><div id="education-33278664" class="editable-item section-item"><div id="education-33278664-view"><div class="education"><a href='/edu/school?id=17926&amp;trk=ppro_sprof' title="More details for this school"><h5 class="education-logo"><img src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_60_60/p/6/005/028/07b/1fc2eba.png" alt="Stanford University"/></h5></a><header><h4 class="summary fn org"><a href='/edu/school?id=17926&amp;trk=ppro_sprof' title="More details for this school">Stanford University</a></h4><h5><span class="degree">M.S., </span><span class="major"><a href="/edu/fos?id=100189&amp;trk=prof-edu-field_of_study" title="Explore this field of study">Computer Science</a></span></h5></header><span class="education-date"><time>1979</time><time> &#8211; 1985</time></span><p class="notes summary-field-show-more">Received an M.D. from the School of Medicine and an M.S. in Computer Science. Designed and built instrumentation for the Dr. Mervin Maze lab to improve the accuracy of highly sensitive HPLC detectors for the measurement of epinephrine levels in human blood matrix.</p></div></div></div><div id="education-33278689" class="editable-item section-item"><div id="education-33278689-view"><div class="education"><a href='/edu/school?id=17929&amp;trk=ppro_sprof' title="More details for this school"><h5 class="education-logo"><img src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_60_60/p/1/005/011/0ca/078e9a1.png" alt="Stanford University School of Medicine"/></h5></a><header><h4 class="summary fn org"><a href='/edu/school?id=17929&amp;trk=ppro_sprof' title="More details for this school">Stanford University School of Medicine</a></h4><h5><span class="degree">M.D., </span><span class="major"><a href="/edu/fos?id=101274&amp;trk=prof-edu-field_of_study" title="Explore this field of study">Medicine</a></span></h5></header><span class="education-date"><time>1979</time><time> &#8211; 1985</time></span><p class="notes summary-field-show-more">Co-editor of the first annual yearbook published in over a decade. Wrote the staff scheduling software for the department of Anesthesia. Developed interface hardware and software to track ambient gasses in the operating room.</p></div></div></div><div id="education-18393452" class="editable-item section-item"><div id="education-18393452-view"><div class="education"><a href='/edu/school?id=17939&amp;trk=ppro_sprof' title="More details for this school"><h5 class="education-logo"><img src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_60_60/p/5/005/079/0ab/29abf9e.png" alt="University of California, Berkeley"/></h5></a><header><h4 class="summary fn org"><a href='/edu/school?id=17939&amp;trk=ppro_sprof' title="More details for this school">University of California, Berkeley</a></h4><h5><span class="degree">A.B., </span><span class="major"><a href="/edu/fos?id=100611&amp;trk=prof-edu-field_of_study" title="Explore this field of study">Biochemistry and Computer Science</a></span></h5></header><span class="education-date"><time>1974</time><time> &#8211; 1979</time></span><p class="notes summary-field-show-more">Double major in Biochemistry and Computer Science. Won an award for solving a previously unsolvable Turing Machine programming problem.</p><p class="activities"><em>Activities and Societies:&nbsp;</em>Undergraduate teaching assistant in two courses: operating systems design and embedded systems design</p></div></div></div><script>if(LI.Dialog){LI.Dialog().submitEvent.subscribe(function(type,args){var educationID;if(args[1]=='removeEducationDialog'&&WebTracking&&WebTracking.trackUserAction){if(args[2]&&args[2].educationID){educationID=args[2].educationID;}WebTracking.trackUserAction('nprofile-edit-education-remove-submit',{educationID:educationID});}});}</script></div></div><div id="background-organizations-container" class="background-section" data-li-template="organizations_section"><div id="background-organizations" class="background-organizations "><h3>Organizations</h3><div id="organization-additional-item" class="section-item editable-item"><div id="organization-additional-item-view"><div class="organization"><h4 class="hidden edit-default">Additional Organizations</h4><p><a href='/vsearch/p?keywords=American+Society+of+Anesthesiologists%0ACalifornia+Society+of+Anesthesiologists&amp;trk=prof-org-additonal_orgs-link' title="Find users with this keyword">American Society of Anesthesiologists
California Society of Anesthesiologists</a></p></div></div></div></div></div><div id="background-honors-container" class="background-section" data-li-template="honors_section"><div id="background-honors" class="background-honors "><h3>Honors &amp; Awards</h3><div id="honors-additional-item" class="section-item editable-item"><div id="honors-additional-item-view"><div class="honoraward"><h4 class="hidden edit-default">Additional Honors &amp; Awards<span class="edit-tools"><a href="javascript:void(0);" class="edit-section" data-trk='{"componentKey":"nprofile-edit-additional_honorawards-form", "source":"prof-edit-background-edit_additional-honorawards-link"}'></a></span></h4><p>Chief Resident, Anesthesia, Massachusetts General Hospital 1989</p></div></div></div></div></div></div></div><script type="text/javascript">fs._server.fire("profile_v2_background_view",{event:"after",type:"html"});</script>
<div id="groups-container">
<script type="text/javascript">fs._server.fire("profile_v2_groups",{event:"before",type:"html"});</script><div id="groups" class="profile-groups " data-total-num-groups="20"><h2>Groups</h2><ul class="groups-container edit-collapse-module"><li class=" rowfirst"><p class="groups-name"><a href="/groups?gid=131338&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/5/005/099/2e5/06a265b.png" width="100" height="50" alt="The College Preparatory School (Oakland, CA)"/></a><a href="/groups?gid=131338&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>The College Preparatory School (Oakland, CA)</strong></a></p></li><li class=""><p class="groups-name"><a href="/groups?gid=2487900&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/2/000/0fc/06a/236d2fe.png" width="100" height="50" alt="Clinical Research and Development Physicians"/></a><a href="/groups?gid=2487900&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>Clinical Research and Development Physicians</strong></a></p></li><li class=""><p class="groups-name"><a href="/groups?gid=3007290&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/3/000/058/38a/27bfe77.png" width="100" height="50" alt="Pharma Physicians"/></a><a href="/groups?gid=3007290&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>Pharma Physicians</strong></a></p></li><li class=""><p class="groups-name"><a href="/groups?gid=4177485&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/3/000/10f/3cc/1ba716e.png" width="100" height="50" alt="MIT Global Entrepreneurship Network"/></a><a href="/groups?gid=4177485&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>MIT Global Entrepreneurship Network</strong></a></p></li><li class=" rowfirst"><p class="groups-name"><a href="/groups?gid=69586&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/4/005/027/1cd/2d468a0.png" width="100" height="50" alt="MIT Massachusetts Institute of Technology Alumni"/></a><a href="/groups?gid=69586&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>MIT Massachusetts Institute of Technology Alumni</strong></a></p></li><li class=""><p class="groups-name"><a href="/groups?gid=1170587&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/2/000/014/340/097f562.png" width="100" height="50" alt="Medical Doctor (MD) Network"/></a><a href="/groups?gid=1170587&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>Medical Doctor (MD) Network</strong></a></p></li><li class=""><p class="groups-name"><a href="/groups?gid=917937&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/6/005/00e/2b8/26c29bc.png" width="100" height="50" alt="Society of Physician Entrepreneurs (SoPE)"/></a><a href="/groups?gid=917937&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>Society of Physician Entrepreneurs (SoPE)</strong></a></p></li><li class="hidden hidden-groups"><p class="groups-name"><a href="/groups?gid=2794764&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/2/000/04c/20d/0ca3cdc.png" width="100" height="50" alt="American Doctors"/></a><a href="/groups?gid=2794764&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>American Doctors</strong></a></p></li><li class="hidden hidden-groups rowfirst"><p class="groups-name"><a href="/groups?gid=118831&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/1/000/00b/006/31818f3.png" width="100" height="50" alt="Physician Entrepreneur"/></a><a href="/groups?gid=118831&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>Physician Entrepreneur</strong></a></p></li><li class="hidden hidden-groups"><p class="groups-name"><a href="/groups?gid=785257&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://s.c.lnkd.licdn.com/scds/common/u/img/icon/group/icon_group_100x50_v2.png" width="100" height="50" alt="Medical Directors"/></a><a href="/groups?gid=785257&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>Medical Directors</strong></a></p></li><li class="hidden hidden-groups"><p class="groups-name"><a href="/groups?gid=2753832&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/1/000/0da/33f/0b0afda.png" width="100" height="50" alt="Physicians in the Pharmaceutical Industry"/></a><a href="/groups?gid=2753832&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>Physicians in the Pharmaceutical Industry</strong></a></p></li><li class="hidden hidden-groups"><p class="groups-name"><a href="/groups?gid=2672460&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/1/000/06a/29c/0546c06.png" width="100" height="50" alt="California Association of Healthcare Leaders/ACHE"/></a><a href="/groups?gid=2672460&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>California Association of Healthcare Leaders/ACHE</strong></a></p></li><li class="hidden hidden-groups rowfirst"><p class="groups-name"><a href="/groups?gid=55208&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/5/005/072/17e/006fc3d.png" width="100" height="50" alt="American Society of Anesthesiologists"/></a><a href="/groups?gid=55208&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>American Society of Anesthesiologists</strong></a></p></li><li class="hidden hidden-groups"><p class="groups-name"><a href="/groups?gid=64882&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/1/000/005/322/1fef84a.png" width="100" height="50" alt="Pharmaceutical Physician"/></a><a href="/groups?gid=64882&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>Pharmaceutical Physician</strong></a></p></li><li class="hidden hidden-groups"><p class="groups-name"><a href="/groups?gid=70245&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/6/005/010/139/03224a4.png" width="100" height="50" alt="Cal Alumni Association | UC Berkeley"/></a><a href="/groups?gid=70245&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>Cal Alumni Association | UC Berkeley</strong></a></p></li><li class="hidden hidden-groups"><p class="groups-name"><a href="/groups?gid=74186&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/2/000/006/270/1bfb5d8.png" width="100" height="50" alt="Stanford University Alumni"/></a><a href="/groups?gid=74186&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>Stanford University Alumni</strong></a></p></li><li class="hidden hidden-groups rowfirst"><p class="groups-name"><a href="/groups?gid=3267353&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/2/000/067/3fd/16f3f11.png" width="100" height="50" alt="Chief Medical Officers (Medical Professionals, Research Experts &amp; Scientists)"/></a><a href="/groups?gid=3267353&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>Chief Medical Officers (Medical Professionals, Research Experts &amp; Scientists)</strong></a></p></li><li class="hidden hidden-groups"><p class="groups-name"><a href="/groups?gid=46140&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/4/000/153/1fa/3e21c07.png" width="100" height="50" alt="Academy of Physicians in Clinical Research"/></a><a href="/groups?gid=46140&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>Academy of Physicians in Clinical Research</strong></a></p></li><li class="hidden hidden-groups"><p class="groups-name"><a href="/groups?gid=1005057&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/6/005/089/344/21cbdd3.png" width="100" height="50" alt="American Association for Physician Leadership"/></a><a href="/groups?gid=1005057&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>American Association for Physician Leadership</strong></a></p></li><li class="hidden hidden-groups"><p class="groups-name"><a href="/groups?gid=3192782&amp;goback=%2Enppvan_reidrubsamenmd&trk=fulpro_grplogo"><img src="http://m.c.lnkd.licdn.com/media/p/1/000/063/29a/084ed22.png" width="100" height="50" alt="Pharmaceutical Physician Forum"/></a><a href="/groups?gid=3192782&amp;goback=%2Enppvan_reidrubsamenmd&trk=prof-groups-membership-name" class="group-link"><strong>Pharmaceutical Physician Forum</strong></a></p></li><li class="see-more"><a class="see-arrow" href=""><span></span></a><a class="see-action" href="javascript:void(0)">See 13 more</a></li><li class="see-less hidden"><a class="see-arrow" href=""><span></span></a><a class="see-action" href="javascript:void(0)">See less</a></li></ul></div><script type="text/javascript">fs._server.fire("profile_v2_groups",{event:"after",type:"html"});</script>
</div>
<script type="text/javascript">fs._server.fire("profile_v2_reg_upsell",{event:"before",type:"html"});</script><div id="secondary-reg-upsell"><div class="public-reg-upsell"><h2>View Reid's full profile to...</h2><ul><li>See who you know in common</li><li>Get introduced</li><li>Contact <strong>Reid</strong> directly</li></ul><a href="https://www.linkedin.com/reg/join-pprofile?_ed=0_dfHO8ItrV_BTL_0P7o4SJRdSf3s7PA64b2wUbD5tRnVt1xr0t0ZUqIgoujj7RAh3sKLgxXcQStAhkFshIq3pz2-cfEKSe5lACsAcFZZguvL&amp;trk=pprof_viewmore" class="signup-button">View Reid's Full Profile</a><p>Not the Reid Rubsamen, M.D. you're looking for? <a href="/pub/dir/?first=Reid&amp;last=Rubsamen%2C+M%2ED%2E">View more</a></p></div></div><script type="text/javascript">fs._server.fire("profile_v2_reg_upsell",{event:"after",type:"html"});</script>
</div>
<div id="aux">
<div class="insights">
<h2>Insights</h2>
<script type="text/javascript">fs._server.fire("profile_v2_locale",{event:"before",type:"html"});</script><script type="text/javascript">fs._server.fire("profile_v2_locale",{event:"after",type:"html"});</script>
<script type="text/javascript">fs._server.fire("profile_v2_name_search",{event:"before",type:"html"});</script><div class="name-search"><h3>Find a different Reid Rubsamen, M.D.</h3><form action="/pub/dir/" method="get"><label for="firstName">First Name</label><script id="control-dust-server-67468979-1" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-67468979-1","GhostLabel",{})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-67468979-1";}</script><input type="text" name="first" id="firstName"/><label for="lastName">Last Name</label><script id="control-dust-server-67468979-2" type="linkedin/control" class="li-control">LI.Controls.addControl("control-dust-server-67468979-2","GhostLabel",{})</script><script type="text/javascript">if(dust&&dust.jsControl){if(!dust.jsControl.flushControlIds){dust.jsControl.flushControlIds="";}else{dust.jsControl.flushControlIds+=",";}dust.jsControl.flushControlIds+="control-dust-server-67468979-2";}</script><input type="text" name="last" id="lastName"/><button aria-label="Search" type="submit"><span></span></button><p class="tip"><strong>Example: </strong> <a href="/pub/dir/?first=Reid&amp;last=Rubsamen%2C+M%2ED%2E">Reid Rubsamen, M.D.</a></p></form></div><script type="text/javascript">fs._server.fire("profile_v2_name_search",{event:"after",type:"html"});</script>
<script type="text/javascript">fs._server.fire("profile_v2_same_name_search",{event:"before",type:"html"});</script><div class="insights-browse-map same-name-search"><ul><li class="first"><a href="http://www.linkedin.com/in/reidrubsamenmd" title="View Reid Rubsamen&#39;s profile" class="browse-map-photo"><img src="http://s.c.lnkd.licdn.com/scds/common/u/images/themes/katy/ghosts/person/ghost_person_60x60_v1.png" title="View Reid Rubsamen&#39;s profile" alt="Reid Rubsamen" width="60" height="60"/></a><h4><a href="http://www.linkedin.com/in/reidrubsamenmd">Reid Rubsamen</a></h4><p class="browse-map-title">OR Medical Director John Muir Med Center at Medical Anesthesia Consultants</p><p class="browse-map-location">San Francisco Bay Area</p></li></ul><a id="same-name-search-more" href="/pub/dir/?first=Reid&last=Rubsamen%2C+M%2ED%2E">More professionals named <span class='name'>Reid Rubsamen, M.D.</span></a></div><script type="text/javascript">fs._server.fire("profile_v2_same_name_search",{event:"after",type:"html"});</script>
<script type="text/javascript">fs._server.fire("profile_v2_browse_map",{event:"before",type:"html"});</script><hr><div class="insights-browse-map"><h3>People Also Viewed</h3><ul><li class="first"><a class="browse-map-photo" title="View Naveen Jain's profile" href='http://www.linkedin.com/pub/naveen-jain/0/599/ba1?trk=pub-pbmap'><img class="" alt="Naveen Jain" width="60" height="60" src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_60_60/p/7/005/057/0f8/1e4f655.jpg"></a><h4><a href="http://www.linkedin.com/pub/naveen-jain/0/599/ba1?trk=pub-pbmap">Naveen Jain</a></h4><p class="browse-map-title">CMO &amp; Co-Founder at Immunity Project</p></li><li><a class="browse-map-photo" title="View Charles Vincent Herst's profile" href='http://www.linkedin.com/pub/charles-vincent-herst/10/aa3/11a?trk=pub-pbmap'><img class="" alt="Charles Vincent Herst" width="60" height="60" src="http://s.c.lnkd.licdn.com/scds/common/u/images/themes/katy/ghosts/person/ghost_person_60x60_v1.png"></a><h4><a href="http://www.linkedin.com/pub/charles-vincent-herst/10/aa3/11a?trk=pub-pbmap">Charles Vincent Herst</a></h4><p class="browse-map-title">Chief Science Officer at Immunity Project</p></li><li><a class="browse-map-photo" title="View Howie Diamond's profile" href='http://www.linkedin.com/pub/howie-diamond/a/571/300?trk=pub-pbmap'><img class="" alt="Howie Diamond" width="60" height="60" src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_60_60/p/4/000/174/143/08a927e.jpg"></a><h4><a href="http://www.linkedin.com/pub/howie-diamond/a/571/300?trk=pub-pbmap">Howie Diamond</a></h4><p class="browse-map-title">Director of Marketing and Strategy at Immunity Project</p></li><li><a class="browse-map-photo" title="View Ian Cinnamon's profile" href='http://www.linkedin.com/pub/ian-cinnamon/16/a85/5b5?trk=pub-pbmap'><img class="" alt="Ian Cinnamon" width="60" height="60" src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_60_60/p/2/000/253/11b/1a1ed7e.jpg"></a><h4><a href="http://www.linkedin.com/pub/ian-cinnamon/16/a85/5b5?trk=pub-pbmap">Ian Cinnamon</a></h4><p class="browse-map-title">Entrepreneur, Author, Creator | MIT, YC, Stanford GSB</p></li><li><a class="browse-map-photo" title="View Tikoes Blankenberg's profile" href='http://www.linkedin.com/pub/tikoes-blankenberg/16/690/406?trk=pub-pbmap'><img class="" alt="Tikoes Blankenberg" width="60" height="60" src="http://s.c.lnkd.licdn.com/scds/common/u/images/themes/katy/ghosts/person/ghost_person_60x60_v1.png"></a><h4><a href="http://www.linkedin.com/pub/tikoes-blankenberg/16/690/406?trk=pub-pbmap">Tikoes Blankenberg</a></h4><p class="browse-map-title">Laboratory Medicine Immunity Project</p></li><li><a class="browse-map-photo" title="View Molly Maloof's profile" href='http://www.linkedin.com/pub/molly-maloof/61/431/480?trk=pub-pbmap'><img class="" alt="Molly Maloof" width="60" height="60" src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_60_60/p/7/005/084/36d/20cc09c.jpg"></a><h4><a href="http://www.linkedin.com/pub/molly-maloof/61/431/480?trk=pub-pbmap">Molly Maloof</a></h4><p class="browse-map-title">Physician at Molly Maloof, MD</p></li><li><a class="browse-map-photo" title="View Shawn Jain's profile" href='http://www.linkedin.com/pub/shawn-jain/5/55b/2aa?trk=pub-pbmap'><img class="" alt="Shawn Jain" width="60" height="60" src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_60_60/p/3/005/012/1c1/2ef19b5.jpg"></a><h4><a href="http://www.linkedin.com/pub/shawn-jain/5/55b/2aa?trk=pub-pbmap">Shawn Jain</a></h4><p class="browse-map-title">Director of Communications at Whitman-Walker Health</p></li><li><a class="browse-map-photo" title="View Alicia Yaffe's profile" href='http://www.linkedin.com/pub/alicia-yaffe/5/2a2/724?trk=pub-pbmap'><img class="" alt="Alicia Yaffe" width="60" height="60" src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_60_60/p/8/000/229/32f/1fc55c4.jpg"></a><h4><a href="http://www.linkedin.com/pub/alicia-yaffe/5/2a2/724?trk=pub-pbmap">Alicia Yaffe</a></h4><p class="browse-map-title">Founder at The Spellbound Group</p></li><li><a class="browse-map-photo" title="View David Heckerman's profile" href='http://www.linkedin.com/pub/david-heckerman/3b/8b7/9ba?trk=pub-pbmap'><img class="" alt="David Heckerman" width="60" height="60" src="http://s.c.lnkd.licdn.com/scds/common/u/images/themes/katy/ghosts/person/ghost_person_60x60_v1.png"></a><h4><a href="http://www.linkedin.com/pub/david-heckerman/3b/8b7/9ba?trk=pub-pbmap">David Heckerman</a></h4><p class="browse-map-title">Distinguished Scientist at Microsoft</p></li><li><a class="browse-map-photo" title="View Riley Ennis's profile" href='http://www.linkedin.com/pub/riley-ennis/19/b5b/260?trk=pub-pbmap'><img class="" alt="Riley Ennis" width="60" height="60" src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_60_60/p/3/005/00e/2e3/0f493f1.jpg"></a><h4><a href="http://www.linkedin.com/pub/riley-ennis/19/b5b/260?trk=pub-pbmap">Riley Ennis</a></h4><p class="browse-map-title">Thiel Fellow | Founder of Immudicon</p></li></ul></div><script type="text/javascript">fs._server.fire("profile_v2_browse_map",{event:"after",type:"html"});</script>
</div>
<div class="right-fixed">
<div class="ganz-module ad">
<script type="text/javascript">fs._server.fire("profile_v2_right_ad",{event:"before",type:"html"});</script><iframe width='300' scrolling='no' height='250' frameborder='0' allowtransparency='true' border='0' data-src='/csp/dtag?sz=300x250&amp;ti=2&amp;p=1&amp;z=full_profile&amp;_x=%3Bcompany%3D2896%3Bcompany%3D56945%3Bcompany%3D16913%3Bcompany%3D5034971%3Bpcntry%3Dus' src='/csp/dtag?sz=300x250&amp;ti=2&amp;p=1&amp;z=full_profile&amp;_x=%3Bcompany%3D2896%3Bcompany%3D56945%3Bcompany%3D16913%3Bcompany%3D5034971%3Bpcntry%3Dus'></iframe><script type="text/javascript">fs._server.fire("profile_v2_right_ad",{event:"after",type:"html"});</script>
</div>
</div>
</div>
</div>
</div>
<div id="page-loading"></div>
<div id="alert-a11y"></div>
<script type="text/javascript">fs._server.fire("profile_v2_view_tracking",{event:"before",type:"html"});</script><script type="text/javascript">fs._server.fire("profile_v2_view_tracking",{event:"after",type:"html"});</script>
<div><iframe data-src="/csp/dtag?sz=1x1&p=8" style="display:none;"></iframe></div>
<script id="control-http-12248-exec-734202-1" type="linkedin/control" class="li-control">LI.Controls.addControl('control-http-12248-exec-734202-1','NonBlockingAdLoad',{});</script>
<div id="directory" class="us">
<h3>
LinkedIn member directory:
</h3>
<ol type="a" class="primary">
<li>
<a href="/directory/people-a">a</a>
</li>
<li>
<a href="/directory/people-b">b</a>
</li>
<li>
<a href="/directory/people-c">c</a>
</li>
<li>
<a href="/directory/people-d">d</a>
</li>
<li>
<a href="/directory/people-e">e</a>
</li>
<li>
<a href="/directory/people-f">f</a>
</li>
<li>
<a href="/directory/people-g">g</a>
</li>
<li>
<a href="/directory/people-h">h</a>
</li>
<li>
<a href="/directory/people-i">i</a>
</li>
<li>
<a href="/directory/people-j">j</a>
</li>
<li>
<a href="/directory/people-k">k</a>
</li>
<li>
<a href="/directory/people-l">l</a>
</li>
<li>
<a href="/directory/people-m">m</a>
</li>
<li>
<a href="/directory/people-n">n</a>
</li>
<li>
<a href="/directory/people-o">o</a>
</li>
<li>
<a href="/directory/people-p">p</a>
</li>
<li>
<a href="/directory/people-q">q</a>
</li>
<li>
<a href="/directory/people-r">r</a>
</li>
<li>
<a href="/directory/people-s">s</a>
</li>
<li>
<a href="/directory/people-t">t</a>
</li>
<li>
<a href="/directory/people-u">u</a>
</li>
<li>
<a href="/directory/people-v">v</a>
</li>
<li>
<a href="/directory/people-w">w</a>
</li>
<li>
<a href="/directory/people-x">x</a>
</li>
<li>
<a href="/directory/people-y">y</a>
</li>
<li>
<a href="/directory/people-z">z</a>
</li>
<li>
<a href="/directory/people-1" class="callout-trigger nlcl-hovercard-trigger">more</a>
</li>
<li class="country-search">
Browse members <a href="/static?key=country_listing">by country</a>
</li>
</ol>
</div>
</div>
</div>
<script type="text/javascript">LI.Controls.processQueue();</script>
<script type="text/javascript">LI_WCT(["control-http-12248-exec-734202-1",]);</script>
<script type="text/javascript">fs._server.fire("964f08a9a138a913f0e6cd8ce92a0000-13",{event:"before",type:"html"});</script><div id="footer" class="remote-nav">
<div class="wrapper">
<p id="copyright" class="guest"><span>LinkedIn Corporation</span> <em>&copy; 2014</em></p>
<ul id="nav-legal">
<li><a href="/legal/user-agreement?trk=hb_ft_userag">User Agreement</a></li>
<li><a href="/legal/privacy-policy?trk=hb_ft_priv">Privacy Policy</a></li>
<li>
<a href="http://help.linkedin.com/app/answers/detail/a_id/34593/loc/na/trk/nprofile_v2_public_fs/" target="_blank" rel="nofollow">Community Guidelines</a>
</li>
<li><a href="/legal/cookie-policy?trk=hb_ft_cookie">Cookie Policy</a></li>
<li class="last"><a href="/legal/copyright-policy?trk=hb_ft_copy">Copyright Policy</a></li>
</ul>
</div>
</div>
<script type="text/javascript">if(LI.showAllDeferredImg){LI.showAllDeferredImg('header',false);LI.showAllDeferredImg('footer',false);}
if(typeof(oUISettings)!=='undefined'){oUISettings.saveSettingsURL="/lite/ui-settings-save-old?csrfToken=ajax%3A8819885718929664622";}
if(typeof(WebTracking)!=='undefined'){WebTracking.saveWebActionTrackURL="/lite/web-action-track?csrfToken=ajax%3A8819885718929664622";}</script>
<script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=3i7ubdukif1jevuf29ftmtvjs-ukgkg4rtwlz74z78bt35jocx-dlcimwl96rttjyfr26x4i92ol-1m7sfcez3isjwlg5yrudwy1mz-clz7gb1h1gqkujqk14gbprnf5"></script>
<script type="text/javascript">fs._server.fire("964f08a9a138a913f0e6cd8ce92a0000-13",{event:"after",type:"html"});</script>
<script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=7ohe7esuw1g26lqingx9rwag1-akfe1g1hb660050homjb2nwnr-9t8kuspsvkr9x9idyawoejfbv&amp;fc=2"></script>
<script type="text/javascript">if(!window.LI){window.LI={};}
LI.RUM=LI.RUM||{};(function(RUM,win){var doc=win.document;RUM.flags=RUM.flags||{};RUM.flags['host-flag']="control";RUM.flags['pop_beacons_frequency']="n100-ap0-la0-va0-sg0-db0";RUM.flags['rs_timings_individual']="control";RUM.urls=RUM.urls||{};RUM.urls['rum-track']="/lite/rum-track?csrfToken=ajax%3A8819885718929664622";RUM.urls['boomerang-bw-img']="http://s.c.lnkd.licdn.com/scds/common/u/lib/boomerang/0.9.edge.4ab208445a/img/";RUM.base_urls=RUM.base_urls||{};RUM.base_urls['permanent_content']="http://s.c.lnkd.licdn.com/scds/common/u/";RUM.base_urls['versioned_content']="http://s.c.lnkd.licdn.com/scds/concat/common/";RUM.base_urls['media_proxy']="http://m.c.lnkd.licdn.com/media-proxy/";RUM.serverStartTime=1.416725824765E12;RUM.enabled=true;function getRumScript(){var node=doc.body||doc.head||doc.getElementsByTagName('head')[0],script=doc.createElement('script');script.src=["http://s.c.lnkd.licdn.com/scds/concat/common/js?h=ed29nkjpsa16bhrjq4na16owq-1mucgfycc664m7vmhpjgqse65-1l5rurej3h44qodo5rn0cdvyn-8om6v2ckrxsbnwf40t9ta8a7e-3hodcd0jtzok6c1m703uzche3-azy45eocivg8ynjidfygmcaex-eaoqba5qd53ry9engxzq6km5n-5ymfqks98x29f5a39qvxdjtq-1m0whdrwis44c1hoa9mrwhlt4-aac54ic1fmca5xz1yvc5t9nfe-kpp4fz3kz2jz1nxf3196utew&fc=2"][0];node.appendChild(script);}
if(win.addEventListener){win.addEventListener('load',getRumScript);}
else{win.attachEvent('onload',getRumScript);}}(LI.RUM,window));</script>
<script id="localChrome"></script>
<script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=enx9cmhmla1jvgcrdsetqudtd-3ute2g4ivrwzi292adtikwnrx-9k5nqxk2bamhakv2zd0ixdhmc-pga7vmnfl2zxgj9h9xzfi4wd-66w8h0pp5z7gzwkzgqz75axwc&amp;fc=2"></script>
<script type="text/javascript">//<![CDATA[
(function(){"use strict";var bcookie=LI.readCookie("bcookie"),urlTemplate="/lite/page-track?ptype=PAGETYPE_PLACEHOLDER&pkey=PAGEKEY_PLACEHOLDER&jsonInfo=TRACKINGINFO_PLACEHOLDER&trk=TRK_PLACEHOLDER";window.ProfilePageTracking=function(pageType,pageKey,trk,jsonTrackingInfo){var url,jsonTrackingInfoStr;if(!bcookie||!pageType||!pageKey){return;}
if(!JSON||!JSON.stringify){return;}
jsonTrackingInfoStr=jsonTrackingInfo&&JSON&&JSON.stringify?JSON.stringify(jsonTrackingInfo):"";url=urlTemplate.replace("PAGETYPE_PLACEHOLDER",pageType).replace("PAGEKEY_PLACEHOLDER",pageKey).replace("TRK_PLACEHOLDER",trk||"").replace("TRACKINGINFO_PLACEHOLDER",jsonTrackingInfoStr);YConn.asyncRequest("get",url,{});};})();
//]]></script>
<script type="text/javascript">//<![CDATA[
(function(require){var bcookie=escape(readCookie("bcookie")),$=window.$||(require&&require('jquery')),newTrkInfo='21917952,'+document.referrer.substr(0,128),alias_secure='https://www.linkedin.com/analytics/noauthtracker?type=leo%2EpageTracking&pageType=full_page&pageKey=nprofile_v2_public_fs_jsbeacon&trkInfo=REPLACEME',alias_normal='/analytics/noauthtracker?type=leo%2EpageTracking&pageType=full_page&pageKey=nprofile_v2_public_fs_jsbeacon&trkInfo=REPLACEME',is_secure=false,url=(is_secure)?alias_secure:alias_normal;function readCookie(name){var nameEQ=name+'=',ca=document.cookie.split(';');for(var i=0;i<ca.length;i++){var c=ca[i];while(c.charAt(0)===' '){c=c.substring(1,c.length);}
if(c.indexOf(nameEQ)===0){return c.substring(nameEQ.length,c.length);}}
return null;}
url=url.replace("REPLACEME",newTrkInfo);if(bcookie){if($&&$.ajax){$.ajax(url);}else if(window.YAHOO){window.YAHOO.util.Connect.asyncRequest('get',url,{});}}})(window.require);
//]]></script>
<script type="text/javascript">var _gaq=_gaq||[];_gaq.push(['_setAccount','UA-3242811-1']);_gaq.push(['_setDomainName','.linkedin.com']);_gaq.push(['_trackPageview','nprofile_v2_public_fs']);_gaq.push(['_setVar','guest']);YEvent.on(window,'load',function(){YAHOO.util.Get.script("http://www.google-analytics.com/ga.js");});</script>
<script type="text/javascript">if(window.dust&&dust.jsControl&&dust.jsControl.flushControlIds){LI_WCT(dust.jsControl.flushControlIds.split(","));dust.jsControl.flushControlIds=null;}
if(window.dust&&dust.jsControl&&dust.jsControl.controlIds){LI_WCT(dust.jsControl.controlIds);dust.jsControl.controlIds=[];}
if(window.LI&&LI.showAllDeferredImg&&!LI.imgDeferFoldCheckDone&&dust&&dust.imgDefer&&dust.imgDefer.imgDeferUsed){LI.showAllDeferredImg(document.body,false);LI.imgDeferFoldCheckDone=true;}</script>
<script type="text/javascript">LI.Controls.processQueue();</script>
<script type="text/javascript">LI.define('Tracking.Comscore');LI.Tracking.Comscore=function(){YAHOO.util.Get.script('http://b.scorecardresearch.com/beacon.js',{onSuccess:function(){COMSCORE.beacon({c1:2,c2:6402952,c3:"",c4:"",c5:"",c6:"",c15:""});}});};YEvent.on(window,'load',LI.Tracking.Comscore);</script>
<noscript>
<img src="http://b.scorecardresearch.com/b?c1=2&amp;c2=6402952&amp;c3=&amp;c4=&amp;c5=&amp;c6=&amp;c15=&amp;cv=1.3&amp;cj=1" style="display:none" width="0" height="0" alt=""/>
</noscript>
<script type="text/javascript">LI.define('Tracking.Quantcast');LI.Tracking.Quantcast=function(){_qoptions={qacct:"p-b3sGjMtCFrexE"};YAHOO.util.Get.script('http://edge.quantserve.com/quant.js');};YEvent.on(window,'load',LI.Tracking.Quantcast);</script>
<noscript>
<a href="http://www.quantcast.com/p-b3sGjMtCFrexE" target="_blank"><img src="http://pixel.quantserve.com/pixel/p-b3sGjMtCFrexE.gif" style="display: none;" height="1" width="1" alt=""/></a>
</noscript>
<script type="text/javascript">YEvent.on(window,'load',function(){(function(){var protocol='http:';var d=new Image(1,1);d.onerror=d.onload=function(){d.onerror=d.onload=null;};d.src=[protocol,"//secure-us.imrworldwide.com/cgi-bin/m?ci=us-603751h&cg=0&cc=1&si=",escape(window.location.href),"&ts=compact&rnd=",(new Date()).getTime()].join('');})();});</script>
<noscript>
<img src="http://secure-us.imrworldwide.com/cgi-bin/m?ci=us-603751h&cg=0&cc=1&ts=noscript" width="1" height="1" alt="" style="display:none"/>
</noscript>
<script type="text/javascript">YEvent.on(window,'load',function(){(function(){var d=new Image(1,1);d.onerror=d.onload=function(){d.onerror=d.onload=null;};d.src="/csp/dtag?p=10";})();});</script>
<noscript>
<img src="/csp/dtag?p=10" width="1" height="1" alt="" style="display:none"/>
</noscript>
</body>
</html>
